<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Cardiovasc Med</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Cardiovasc Med</journal-id>
<journal-id journal-id-type="publisher-id">Front. Cardiovasc. Med.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Cardiovascular Medicine</journal-title>
</journal-title-group>
<issn pub-type="epub">2297-055X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31119135</article-id>
<article-id pub-id-type="pmc">6507622</article-id>
<article-id pub-id-type="doi">10.3389/fcvm.2019.00054</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cardiovascular Medicine</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Autoimmune Calcium Channelopathies and Cardiac Electrical Abnormalities</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Qu</surname>
<given-names>Yongxia Sarah</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/483676/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lazzerini</surname>
<given-names>Pietro Enea</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/158877/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Capecchi</surname>
<given-names>Pier Leopoldo</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Laghi-Pasini</surname>
<given-names>Franco</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>El Sherif</surname>
<given-names>Nabil</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/34336/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Boutjdir</surname>
<given-names>Mohamed</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/196373/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Cardiology, New York Presbyterian Brooklyn Methodist Hospital</institution>, <addr-line>Brooklyn, NY</addr-line>, <country>United States</country></aff>
<aff id="aff2"><sup>2</sup><institution>VA New York Harbor Healthcare System and State University of New York Downstate Medical Center</institution>, <addr-line>Brooklyn, NY</addr-line>, <country>United States</country></aff>
<aff id="aff3"><sup>3</sup><institution>Department of Medical Sciences, Surgery and Neurosciences, University of Siena</institution>, <addr-line>Siena</addr-line>, <country>Italy</country></aff>
<aff id="aff4"><sup>4</sup><institution>NYU School of Medicine</institution>, <addr-line>New York, NY</addr-line>, <country>United States</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Shimon Rosenheck, Meir Medical Center, Israel</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Daniel M. Johnson, University of Birmingham, United Kingdom; Martin Ibarrola, Independent Researcher, Bella Vista, Argentina; Thomas Hund, The Ohio State University, United States</p>
</fn>
<corresp id="c001">*Correspondence: Yongxia Sarah Qu <email>ysq9001@nyp.org</email></corresp>
<fn fn-type="other" id="fn001">
<p>This article was submitted to Cardiac Rhythmology, a section of the journal Frontiers in Cardiovascular Medicine</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>02</day>
<month>5</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>6</volume>
<elocation-id>54</elocation-id>
<history>
<date date-type="received">
<day>07</day>
<month>11</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>16</day>
<month>4</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2019 Qu, Lazzerini, Capecchi, Laghi-Pasini, El Sherif and Boutjdir.</copyright-statement>
<copyright-year>2019</copyright-year>
<copyright-holder>Qu, Lazzerini, Capecchi, Laghi-Pasini, El Sherif and Boutjdir</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Patients with autoimmune diseases are at increased risk for developing cardiovascular diseases, and abnormal electrocardiographic findings are common. Voltage-gated calcium channels play a major role in the cardiovascular system and regulate cardiac excitability and contractility. Particularly, by virtue of their localization and expression in the heart, calcium channels modulate pace making at the sinus node, conduction at the atrioventricular node and cardiac repolarization in the working myocardium. Consequently, emerging evidence suggests that calcium channels are targets to autoantibodies in autoimmune diseases. Autoimmune-associated cardiac calcium channelopathies have been recognized in both sinus node dysfunction atrioventricular block in patients positive for anti-Ro/La antibodies, and ventricular arrhythmias in patients with dilated cardiomyopathy. In this review, we discuss mechanisms of autoimmune-associated calcium channelopathies and their relationship with the development of cardiac electrical abnormalities.</p>
</abstract>
<kwd-group>
<kwd>calcium channel</kwd>
<kwd>autoantibodies</kwd>
<kwd>autoimmune</kwd>
<kwd>channelopathy</kwd>
<kwd>cardiac electrical abnormalities</kwd>
</kwd-group>
<counts>
<fig-count count="4"></fig-count>
<table-count count="1"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="128"></ref-count>
<page-count count="12"></page-count>
<word-count count="9218"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Voltage gated calcium channels (VGCCs) are macromolecular complexes which include the main pore forming α<sub>1</sub>-subunits, the accessory β, α<sub>2</sub>δ, and γ-subunits (<xref ref-type="bibr" rid="B1">1</xref>–<xref ref-type="bibr" rid="B4">4</xref>). In the heart, VGCCs mediate calcium (Ca) influx in response to membrane depolarization and modulate excitability, contraction, hormonal secretion and gene transcription (<xref ref-type="bibr" rid="B1">1</xref>–<xref ref-type="bibr" rid="B6">6</xref>). There are many pathologies, both genetic and acquired, involving VGCCs. Mutations in VGCCs cause dysfunctions of Ca channels, resulting in abnormal excitation of the cardiomyocyte, and cardiac arrhythmias (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B6">6</xref>–<xref ref-type="bibr" rid="B8">8</xref>), which contribute substantially to morbidity and mortality. Among the different pathophysiological mechanisms of arrhythmogenesis, a new area of interest has recently emerged and is related to autoimmune-associated Ca channel dysfunction (autoimmune Ca channelopathies) in cardiac arrhythmias (<xref ref-type="bibr" rid="B9">9</xref>–<xref ref-type="bibr" rid="B12">12</xref>). This review summarizes the recent findings on the roles of cardiac Ca channels in autoantibodies-associated cardiac arrhythmias.</p>
</sec>
<sec id="s2">
<title>Voltage-Gated Calcium Channels in the Heart</title>
<p>L-type and T-type Ca channels are the two major classes of VGCCs in the heart. The L-type Ca channel is a high voltage-activated, long-lasting, and the T-type channel is characterized by a low voltage-activated, transient-type channel (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B14">14</xref>). There are 10 isoforms of mammalian genes encoding the α<sub>1</sub> subunit. (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B15">15</xref>–<xref ref-type="bibr" rid="B18">18</xref>). <italic>CACNA1S, CACNA1C, CACNA1D</italic>, and <italic>CACNA1F</italic> encode α<sub>1S</sub>, α<sub>1C</sub>, α<sub>1D</sub>, and α<sub>1F</sub> subunits (L-type Ca channels) respectively. <italic>CACNA1A, CACNA1B</italic>, and <italic>CACNA1E</italic> encode α<sub>1A</sub>, α<sub>1B</sub>, and α<sub>1E</sub> subunits (P/Q-, N-, and R-types), respectively, (<xref ref-type="bibr" rid="B19">19</xref>–<xref ref-type="bibr" rid="B21">21</xref>). The T-type Ca channels α<sub>1G</sub>, α<sub>1H</sub>, and α<sub>1I</sub> subunits are encoded by <italic>CACNA1G, CACNA1H</italic>, and <italic>CACNA1I</italic>, respectively, (<xref ref-type="bibr" rid="B22">22</xref>–<xref ref-type="bibr" rid="B24">24</xref>). Among these channels, the L-type Ca channels α<sub>1C</sub> and α<sub>1D</sub> isoforms and the T-type Ca channels α<sub>1G</sub> and α<sub>1H</sub> isoforms are the major VGCCs expressed in the heart (<xref ref-type="bibr" rid="B25">25</xref>–<xref ref-type="bibr" rid="B27">27</xref>). The features and tissue distribution of the L-type and T-type Ca channels are summarized in <xref ref-type="table" rid="T1">Table 1</xref>.</p>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p>Features of Ca channels in the heart.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Channel</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Gene</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Activation</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Distribution</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Developmental change</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Function</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">α<sub>1C</sub> VGCC</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cav1.2</td>
<td align="left" colspan="1" rowspan="1" valign="top">−40 mV</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ubiquitous</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increase with developmental stage</td>
<td align="left" colspan="1" rowspan="1" valign="top">• Action potential in SAN and AVN,<break></break> • Inotropy, contraction of atria and ventricles</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">α<sub>1D</sub> VGCC</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cav1.3</td>
<td align="left" colspan="1" rowspan="1" valign="top">−60 mV</td>
<td align="left" colspan="1" rowspan="1" valign="top">SAN, AVN, Atria in adult heart; Ubiquitous in immature heart</td>
<td align="left" colspan="1" rowspan="1" valign="top">Decrease with developmental stage</td>
<td align="left" colspan="1" rowspan="1" valign="top">• Pace making,<break></break> • AVN conduction<break></break> • Atrial excitability</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">α<sub>1G</sub> VGCC</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cav3.1</td>
<td align="left" colspan="1" rowspan="1" valign="top">−70 mV</td>
<td align="left" colspan="1" rowspan="1" valign="top">Supraventricular tissue, 30-fold more in SAN than in atria</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increase during development, maximal at adult stage</td>
<td align="left" colspan="1" rowspan="1" valign="top">• Pacing making<break></break> • AVN conduction</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">α<sub>1H</sub> VGCC</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cav3.2</td>
<td align="left" colspan="1" rowspan="1" valign="top">−70 mV</td>
<td align="left" colspan="1" rowspan="1" valign="top">Supraventricular tissue</td>
<td align="left" colspan="1" rowspan="1" valign="top">Predominant in embryonic stage</td>
<td colspan="1" rowspan="1"></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>references (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B28">28</xref>–<xref ref-type="bibr" rid="B35">35</xref>)</italic>.</p>
</table-wrap-foot>
</table-wrap>
<sec>
<title>L-type Ca Channels in the Heart</title>
<sec>
<title>α<sub>1C</sub> L-type Ca Channel</title>
<p>Cardiac α<sub>1C</sub> L-type VGCC is a protein complex comprised of α<sub>1C</sub>, β<sub>2</sub>, and α<sub>2</sub>/δ subunits. The α<sub>1</sub> subunit is the pore-forming subunit, which determines the major features of the channel, such as ion selectivity, activation-inactivation and the sensitivity to Ca channel blockers (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B16">16</xref>). The β<sub>2</sub> and α<sub>2</sub>/δ accessory subunits play important roles in the regulation of the biophysical properties of Ca channels (<xref ref-type="bibr" rid="B36">36</xref>). The α<sub>1C</sub> VGCC is universally expressed in the heart and plays a critical role in excitation–contraction coupling, impulse generation in sinus node (SAN) and its conduction in the atrioventricular node (AVN). The Ca ions entering the cardiomyocytes through α<sub>1C</sub> VGCCs also shape the plateau phase of the ventricular action potential and induce the release of Ca from the sarcoplasmic reticulum (calcium induced-calcium release) which initiates the myocardial contraction (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B36">36</xref>).</p>
</sec>
<sec>
<title>α<sub>1D</sub> L-type Ca Channel</title>
<p>In contrast to the ubiquitously expressed α<sub>1C</sub> VGCCs in the heart, α<sub>1D</sub> VGCCs are restricted to the supraventricular tissue of the adult heart, with the highest expression in the atria, SAN, and AVN, but they are not expressed in the normal adult ventricles (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B37">37</xref>–<xref ref-type="bibr" rid="B42">42</xref>). In the fetal heart, however, α<sub>1D</sub> VGCCs are expressed throughout the heart including the ventricles, atria, SAN, and AVN (<xref ref-type="bibr" rid="B39">39</xref>). While α<sub>1C</sub> VGCCs activate at more positive (−40 and −30 mV) potentials, α<sub>1D</sub> VGCCs activate between −60 and −40 mV at a range of diastolic depolarization of the SAN (<xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B42">42</xref>). This unique feature allows α<sub>1D</sub> VGCCs to play an important role in the automaticity of SAN pacemaker cells (<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B43">43</xref>, <xref ref-type="bibr" rid="B44">44</xref>). The unexpected SAN dysfunction reported in mice lacking α<sub>1D</sub> VGCCs was the first evidence of their importance in heart automaticity (<xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B42">42</xref>, <xref ref-type="bibr" rid="B44">44</xref>). Deletion of the α<sub>1D</sub> VGCC gene impairs pace making in the SAN and atrioventricular conduction in the AVN but has no effect on myocardial contractility (<xref ref-type="bibr" rid="B42">42</xref>, <xref ref-type="bibr" rid="B44">44</xref>).</p>
</sec>
</sec>
<sec>
<title>T-type Ca Channels in the Heart</title>
<p>There are 3 isoforms of T-type VGCC: α<sub>1G</sub> (<xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B45">45</xref>), α<sub>1H</sub> (<xref ref-type="bibr" rid="B24">24</xref>), and α<sub>1I</sub> (<xref ref-type="bibr" rid="B45">45</xref>, <xref ref-type="bibr" rid="B46">46</xref>). Among them, α<sub>1G</sub> and α<sub>1H</sub> are the major isoforms in the myocardium and their expression is developmentally regulated (<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B30">30</xref>, <xref ref-type="bibr" rid="B31">31</xref>). While α<sub>1H</sub> T-type VGCC constitutes the predominant isoform in embryonic heart tissue (<xref ref-type="bibr" rid="B32">32</xref>); α<sub>1G</sub> T-type VGCC expression increases during the perinatal period and reaches its maximal level in adulthood. In adult SAN, α<sub>1G</sub> expression is higher than α<sub>1H</sub> T-type VGCC (<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B33">33</xref>). In contrast to α<sub>1D</sub> L-type VGCC, which requires accessary subunits for normal gating, α<sub>1G</sub> or α<sub>1H</sub> subunits expression alone exhibit native T-type Ca channel properties (<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B47">47</xref>, <xref ref-type="bibr" rid="B48">48</xref>). In addition, T-type VGCCs open at significantly more negative membrane potentials that overlap the pacemaker potentials of SAN cells (<xref ref-type="bibr" rid="B30">30</xref>, <xref ref-type="bibr" rid="B49">49</xref>). The threshold for activation is −70 to −60 mV, and the channel is fully activated at −30 to −10 mV (<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B31">31</xref>, <xref ref-type="bibr" rid="B49">49</xref>). T-type VGCCs are expressed in the SAN (<xref ref-type="bibr" rid="B34">34</xref>), the AVN (<xref ref-type="bibr" rid="B50">50</xref>), and the Purkinje fibers (<xref ref-type="bibr" rid="B51">51</xref>, <xref ref-type="bibr" rid="B52">52</xref>), supporting their roles in the generation of the diastolic depolarization, the automaticity of SAN and the impulse conduction of the heart (<xref ref-type="bibr" rid="B30">30</xref>, <xref ref-type="bibr" rid="B31">31</xref>, <xref ref-type="bibr" rid="B53">53</xref>, <xref ref-type="bibr" rid="B54">54</xref>). Indeed, homozygous transgenic mice lacking α<sub>1G</sub> VGCC exhibit first-degree atrioventricular block (AVB) and bradycardia (<xref ref-type="bibr" rid="B25">25</xref>). Collectively, both L-type, and T-type Ca channels by virtue of their tissue-specific localization can modulate automaticity, conduction and repolarization, and as such, agents and compounds like autoantibodies (discussed below) which interact and target these channels are expected to affect the electrical activity of the heart.</p>
</sec>
</sec>
<sec id="s3">
<title>Autoantibodies-Associated Cardiac Calcium Channelopathies</title>
<p>Autoimmune disorders and cardiovascular disorders are associated with significant morbidity and mortality and are a major health problem both in the USA and worldwide. While the field of “cardio-immunology” is being formally established, recent and emerging advances in this area indicate that autoantibodies play an important role in the development of cardiac arrhythmias.</p>
<sec>
<title>Autoantibodies Against Ca Channel and Ventricular Arrhythmias: Anti-α<sub>1C</sub> Subunit Antibody</title>
<p>Autoimmunity is one of the main mechanisms involved in the pathogenesis of dilated cardiomyopathy (DCM) (<xref ref-type="bibr" rid="B55">55</xref>–<xref ref-type="bibr" rid="B57">57</xref>). Sudden death caused by ventricular arrhythmias is one of the leading causes of death in patients with DCM (<xref ref-type="bibr" rid="B58">58</xref>–<xref ref-type="bibr" rid="B60">60</xref>). Results from previous studies indicated that the VGCC plays an important role in the pathogenesis of DCM (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B61">61</xref>, <xref ref-type="bibr" rid="B62">62</xref>). The function of VGCCs in DCM is affected either by autoantibodies directed against the regulatory pathway/accessary subunits or autoantibodies targeting the pore forming α<sub>1</sub> subunit itself. Several autoantibodies indirectly affecting the L-type VGCCs have been identified in patients with DCM (<xref ref-type="bibr" rid="B63">63</xref>–<xref ref-type="bibr" rid="B65">65</xref>). The presence of antibody against the β-adrenoceptor was first reported in a patient with Chagas' disease by Sterin-Borda et al. (<xref ref-type="bibr" rid="B66">66</xref>). Ten years later, Wallukat and Wollenberger demonstrated the presence of an agonist-like anti-β1 adrenoceptor in DCM patients (<xref ref-type="bibr" rid="B67">67</xref>). Subsequent studies showed that these autoantibodies in DCM target the second extra-cellular loop of the β1-adrenoreptor (<xref ref-type="bibr" rid="B68">68</xref>), resulting in a positive chronotropic effect. Autoantibodies against β1-adrenoceptors were closely related to ventricular arrhythmias in patients with DCM (<xref ref-type="bibr" rid="B69">69</xref>). Anti-β1-adrenoceptor antibodies induced in an animal model caused action potential duration prolongation, with higher propensity for induction of early repolarization, promoting the development of ventricular arrhythmias which increased the risk of sudden death (<xref ref-type="bibr" rid="B69">69</xref>–<xref ref-type="bibr" rid="B71">71</xref>). Notably, Christ et al. (<xref ref-type="bibr" rid="B72">72</xref>) demonstrated that anti-β1 adrenoceptor antibodies increased L-Type Ca current, I<sub>Ca−L</sub> in adult rat ventricular cells in concordance with the prolongation of the action potential duration. Autoantibodies against adenine nucleotide translocators, which cross-react with VGCCs, increases the Ca inflow which causes myocyte damage by Ca overload in DCM (<xref ref-type="bibr" rid="B73">73</xref>–<xref ref-type="bibr" rid="B75">75</xref>).</p>
<p>The evidence of the presence of agonist-like autoantibodies directly against the L-type VGCC α<sub>1C</sub> subunits in DCM was demonstrated by Liao et al. (<xref ref-type="bibr" rid="B76">76</xref>) and Xiao et al. (<xref ref-type="bibr" rid="B11">11</xref>) subsequently demonstrated that autoantibodies against α<sub>1C</sub> Ca channel are arrhythmogenic and lead to sudden cardiac death in patients with DCM. In a prospective study, the authors compared ventricular arrhythmias and sudden death in 80 patients with DCM and age- and gender-matched controls for 32 months. Autoantibodies against L-type α<sub>1C</sub> subunits (anti-α<sub>1C</sub>) were detected by ELISA in 39 patients with DCM (48.8%) and 5 controls (6.3%). Higher incidence of ventricular arrhythmias and sudden cardiac death was observed in anti-α<sub>1C</sub> antibody-positive patients as compared to the antibody-negative patients. The presence of anti-α<sub>1C</sub> antibodies was identified as the strongest independent predictor for sudden death in DCM (<xref ref-type="bibr" rid="B11">11</xref>). The arrhythmogenic effect of anti-α<sub>1C</sub> antibodies was reproduced in a rat model (<xref ref-type="bibr" rid="B11">11</xref>). Perfusion of affinity purified anti-α<sub>1C</sub> antibodies lead to ventricular arrhythmias by action potential duration prolongation and triggered activity (<xref ref-type="bibr" rid="B11">11</xref>). This effect was blocked by pre-incubating the anti-α<sub>1C</sub> antibodies with its specific peptide and Ca channel blockers, indicating the specificity of the arrhythmogenic effect of the anti-α<sub>1C</sub> antibodies (<xref ref-type="bibr" rid="B11">11</xref>). To further investigate the underlying mechanism of the anti-α<sub>1C</sub> antibodies, Xiao et al. using immunofluorescent approach demonstrated that anti-α<sub>1C</sub> antibodies were able specifically to bind to the Ca channel on the myocyte, enhancing the channel's activities (hence the agonist-like effect). In a prospective study, Yu et al. (<xref ref-type="bibr" rid="B62">62</xref>) recruited 2096 patients with congestive heart failure, of which 841 dilated cardiomyopathy patients (DMC) 1,255 ischemic cardiomyopathy (ICM) patients, and 834 controls. By the end of a median follow up of 52 months, 102 cases of DCM had sudden cardiac death. Interestingly, the rate of anti-Ca channel antibody in DCM was significantly higher in DCM patients compared to controls. After adjusting for risk factor including age, left ventricular ejection fraction (LVEF), hypertension, diabetes, New York Heart Association (NYHA) functional classification, QTc, and medications, Cox regression analysis revealed that the presence of anti-Ca channel antibodies still remains an independent risk factor for sudden cardiac death in DCM patients. In conclusion, there are novel agonist-like anti-α<sub>1C</sub> Ca channel antibodies in patients with DCM, which prolong action potential duration and QT interval, induce early after depolarizations, and ventricular tachycardia, eventually leading to sudden cardiac death. These antibodies could serve as novel clinical markers and as positive predictor of sudden death in DCM (<xref ref-type="fig" rid="F1">Figure 1</xref>) (<xref ref-type="bibr" rid="B61">61</xref>, <xref ref-type="bibr" rid="B62">62</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p>Proposed mechanism of the pathogenic role of anti-Ca channels autoantibodies in Dilated Cardiomyopathy. Anti-Ca channels autoantibodies target L-type Ca channels in the ventricular myocyte resulting in an increase in L-type Ca current (I<sub>CaL</sub>) which in turn leads to action potential prolongation and ventricular arrhythmias.</p>
</caption>
<graphic xlink:href="fcvm-06-00054-g0001"></graphic>
</fig>
</sec>
<sec>
<title>Autoimmune-Associated Brady-Arrhythmias and Conduction Abnormalities: Cardiac L-type Ca Channels and Anti-ro Antibodies</title>
<p>While presence of the anti-α<sub>1C</sub> Ca channel antibody is identified as a strong predictor for ventricular arrhythmias and sudden cardiac death in DCM (<xref ref-type="bibr" rid="B11">11</xref>), its role has not been well-established in other autoimmune-associated cardiac electrical abnormalities. The best studied disease caused by autoantibody related L-type Ca channel dysfunction is autoimmune-associated congenital heart block (CHB) characterized by AVB, and sinus bradycardia (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B35">35</xref>, <xref ref-type="bibr" rid="B77">77</xref>–<xref ref-type="bibr" rid="B80">80</xref>). CHB is a conduction abnormality that affects structurally normal hearts of fetuses and/or newborn to mothers with autoantibodies against the intracellular ribonucleoproteins SSA-Ro and SSB-La (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B79">79</xref>, <xref ref-type="bibr" rid="B80">80</xref>). The hallmark of CHB is various degrees of AVB, with complete AVB being the most common, for which more than 60% of affected children require lifelong pacemakers (<xref ref-type="bibr" rid="B81">81</xref>), and carries mortality rate up to 30% (<xref ref-type="bibr" rid="B81">81</xref>, <xref ref-type="bibr" rid="B82">82</xref>). Because anti-Ro antibodies are the most prevalent autoantibodies in CHB (<xref ref-type="bibr" rid="B83">83</xref>–<xref ref-type="bibr" rid="B85">85</xref>), anti-La antibodies are not discussed in this review. There are 2 subtypes of anti-Ro autoantibodies: anti-52 and anti-60 kD SSA/Ro (collectively termed anti-Ro antibodies in this review). Anti-Ro antibodies result from an autoimmune response to the SSA-Ro antigen, which is an intracellular ribonucleoprotein that is not accessible to the circulating anti-Ro antibodies in the normal cardiac myocyte, likely because of their large size. Anti-Ro antibodies are more prevalent in certain autoimmune diseases including Sjögren's syndrome, systemic lupus erythematosus, scleroderma, rheumatoid arthritis, systemic sclerosis, and myositis (<xref ref-type="bibr" rid="B86">86</xref>, <xref ref-type="bibr" rid="B87">87</xref>). Intriguingly, these anti-Ro antibodies are also present in the general healthy population (<xref ref-type="bibr" rid="B87">87</xref>–<xref ref-type="bibr" rid="B89">89</xref>). The incidence of CHB is about 1:11,000 (<xref ref-type="bibr" rid="B81">81</xref>, <xref ref-type="bibr" rid="B90">90</xref>); however, this incidence dramatically increases to about 5% in anti-Ro positive mothers and up to 18% in subsequent pregnancies thereby affecting the decision to have a second child (<xref ref-type="bibr" rid="B79">79</xref>, <xref ref-type="bibr" rid="B81">81</xref>). The causal relationship of anti-Ro antibodies to the development of CHB was reproduced in both active and passive mice models of CHB (<xref ref-type="bibr" rid="B81">81</xref>, <xref ref-type="bibr" rid="B91">91</xref>–<xref ref-type="bibr" rid="B93">93</xref>). Various degree of AVB developed in pups born to female mice immunized with recombinant 52 SSA/Ro protein (active immunization) (<xref ref-type="bibr" rid="B81">81</xref>, <xref ref-type="bibr" rid="B93">93</xref>, <xref ref-type="bibr" rid="B94">94</xref>). Transfer of anti-Ro antibodies from mothers with CHB children (anti-Ro antibody positive IgG) directly into timely pregnant mice also resulted in first degree AVB and, surprisingly, sinus bradycardia in about 70% of the pups (passive immunization) (<xref ref-type="bibr" rid="B91">91</xref>). Similarly, clinical data (<xref ref-type="bibr" rid="B95">95</xref>, <xref ref-type="bibr" rid="B96">96</xref>) also confirmed similar sinus bradycardia in newborns of mothers with anti-Ro antibody positive IgG, indicating that the spectrum of CHB extends beyond AVN to also affect SAN.</p>
<sec>
<title>Anti-Ro Antibody Positive IgG Inhibits Both α<sub>1C</sub> and α<sub>1D</sub> Ca Currents</title>
<p>As mentioned above, the hallmark of CHB is AVB. The conduction of the impulse through the AVN depends critically on α<sub>1C</sub> Ca current, I<sub>Ca−L</sub>, which activates at more positive (−40 and −30 mV) potentials (<xref ref-type="bibr" rid="B97">97</xref>). It is logical to speculate that anti-Ro antibody positive IgG might target α<sub>1C</sub> Ca channel to disturb the electrical conduction at AVN as seen in CHB. Anti-Ro antibody positive IgG and affinity purified anti-52 Ro antibodies from mothers with CHB children, but not anti-Ro antibody negative IgG from healthy mothers, inhibited I<sub>Ca−L</sub> in isolated SAN, AVN cells, Purkinje fibers and in ventricular cells by 50–59% (<xref ref-type="bibr" rid="B77">77</xref>, <xref ref-type="bibr" rid="B78">78</xref>, <xref ref-type="bibr" rid="B98">98</xref>–<xref ref-type="bibr" rid="B100">100</xref>). In addition, anti-Ro antibody positive IgG had no effect on K currents (the transient outward current, I<sub>to</sub> and the inward rectifier, I<sub>K1</sub>), or the Na current (I<sub>Na</sub>), indicating its specificity toward Ca channels (<xref ref-type="bibr" rid="B98">98</xref>). To exclude the possibility of potential contamination from other ion currents, α<sub>1C</sub> Ca channels expressed in Xenopus oocytes were similarly inhibited about 50% by anti-Ro antibody positive IgG (<xref ref-type="bibr" rid="B92">92</xref>, <xref ref-type="bibr" rid="B99">99</xref>, <xref ref-type="bibr" rid="B100">100</xref>).</p>
<p>While inhibition of α<sub>1C</sub> I<sub>Ca−L</sub> could account for the AVB seen in CHB, the contribution of α<sub>1C</sub> I<sub>Ca−L</sub> to diastolic depolarization of the SA node is generally considered to be minor. SAN pacemaker depolarization occurs between −60 and −40 mV; however α<sub>1C</sub> I<sub>Ca−L</sub> activates at more positive (−40 and −30 mV) potentials (<xref ref-type="bibr" rid="B101">101</xref>). Knockout of the α<sub>1D</sub> Ca channel, which activates at −60 and −40 mV in mice, results in significant sinus bradycardia and AVB (<xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B42">42</xref>, <xref ref-type="bibr" rid="B102">102</xref>), a phenotype reminiscent to that seen in CHB. Mangoni et al. (<xref ref-type="bibr" rid="B44">44</xref>) showed I<sub>Ca−L</sub> in SAN cells was decreased by 75% in α<sub>1D</sub> Ca channel knockout mice compared with wild-type mice, which indicates that the contribution of the α<sub>1D</sub> Ca channel to total I<sub>Ca−L</sub> is significant in the mouse SA node cell. Furthermore, our previous studies demonstrated that both α<sub>1D</sub> Ca channel transcripts and proteins are expressed in human fetal heart and in adult rabbit SAN (<xref ref-type="bibr" rid="B39">39</xref>, <xref ref-type="bibr" rid="B40">40</xref>). Collectively, these data suggest that α<sub>1D</sub>, along with α<sub>1C</sub>, contribute to form I<sub>Ca−L</sub>, playing a critical role in pace making activity in SAN and are a potential target by anti-Ro antibodies. Because there are no biophysical methods or specific blockers to separate α<sub>1D</sub> from α<sub>1C</sub> I<sub>CaL</sub> in native cells, the specific effect of anti-Ro antibodies on α<sub>1D</sub> I<sub>Ca−L</sub> has been challenging. Initial studies were carried out in expression systems to allow individual expression of α<sub>1D</sub> I<sub>Ca−L</sub> to characterize the effect of anti-Ro antibody positive IgG<sub>.</sub> Anti-Ro antibody positive IgG from mothers with CHB children inhibited α<sub>1D</sub> I<sub>Ca−L</sub> by about 43% in tsA201 cells and about 33% in Xenopus oocytes (<xref ref-type="bibr" rid="B40">40</xref>, <xref ref-type="bibr" rid="B77">77</xref>, <xref ref-type="bibr" rid="B78">78</xref>, <xref ref-type="bibr" rid="B92">92</xref>, <xref ref-type="bibr" rid="B99">99</xref>, <xref ref-type="bibr" rid="B100">100</xref>). To overcome this limitation of using expression systems, our group has tested the effect of anti-Ro antibodies on α<sub>1D</sub> I<sub>Ca−L</sub> in native neonatal cardiomyocytes, in which the α<sub>1C</sub> gene was effectively silenced by lentivirus. Adding anti-Ro antibody positive IgG resulted in 35% reduction of α<sub>1D</sub> I<sub>Ca−L</sub> in naïve cardiomyocytes (<xref ref-type="bibr" rid="B103">103</xref>), similar to the results seen using expression systems.</p>
<p>Because anti-Ro antibodies inhibit both α<sub>1C</sub> and α<sub>1D</sub> I<sub>Ca−L</sub>, it is anticipated that anti-Ro antibodies will cause both sinus bradycardia and AVB. Further experimental evidence using isolated multicellular AVN preparations (<xref ref-type="fig" rid="F2">Figures 2A,B</xref>) and Langendorff-perfused whole hearts (<xref ref-type="fig" rid="F2">Figures 2C–E</xref>) demonstrated that anti-Ro antibody positive IgG resulted in bradycardia associated with 2:1 AVB then complete third degree AVB as recorded by surface EG. In contrast, perfusion of the AVN preparation or whole heart with control anti-Ro antibody negative IgG had no effect on ECG parameters (<xref ref-type="bibr" rid="B78">78</xref>). The sinus bradycardia and AVB were also demonstrated in Langendorff-perfused human hearts by our group (<xref ref-type="bibr" rid="B77">77</xref>) and by others (<xref ref-type="bibr" rid="B104">104</xref>, <xref ref-type="bibr" rid="B105">105</xref>). Similar findings were obtained using the optical mapping technique, which allows simultaneous recording of voltage action potentials at multiple areas of the heart including the AVN area. Perfusion of hearts with anti-Ro antibody positive IgG revealed the sites of conduction abnormalities at the sinoatrial junction and AVN, thereby confirming the site of action for these autoantibodies (<xref ref-type="bibr" rid="B106">106</xref>).</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption>
<p>Effects of anti-Ro antibodies from mothers of children with congenital heart block on an isolated multicellular AV nodal preparation (left) and Langendorff perfused whole heart (Right). <bold>(A)</bold> Simultaneous control action potentials from the crista terminalis (black tracing) and the AV node area (red tracing). <bold>(B)</bold> Superfusion of the preparation with positive IgG (800 μg/mL) for 10 min resulted in 2:1 AV block (indicated by the arrows) which progressed to near complete inhibition of the AV node action potential by 15 min <bold>(B)</bold>, (green tracing). <bold>(C)</bold> ECG was recorded by the conventional ECG machine in lead I, except for the use of silver wires at the recording end of the leads. One lead was inserted in the atrium, the second in the left ventricle near the apex, and the third in Tyrode's solution (ground). “P” indicates, the P wave and on the ECG. Regular sinus rhythm (horizontal scale, 50 mm/s and vertical scale: 5 mm/mV) at 300 beats/min in Tyrode's solution. <bold>(D)</bold> After 5 min of perfusion with positive IgG (800 μg/mL), there was bradycardia associated with a 2:1 second degree AV block that degenerated into complete AV block by 15 min of IgG perfusion <bold>(E)</bold>. The sectioned heart in the middle panel illustrates the location of the microelectrode recordings.</p>
</caption>
<graphic xlink:href="fcvm-06-00054-g0002"></graphic>
</fig>
<p>In summary, α<sub>1D</sub> and α<sub>1C</sub> Ca channels both contribute to total I<sub>Ca−L</sub> in the heart, with α<sub>1D</sub> Ca channels playing a more critical role in the SAN and α<sub>1C</sub> Ca channels in the AVN. Anti-Ro antibodies inhibit I<sub>Ca−L</sub> emanating from both α<sub>1D</sub> and α<sub>1C</sub>, resulting in AVB and sinus bradycardia seen in CHB. This causal relationship was confirmed by reproducing active and passive mice CHB models by induction of anti-Ro antibodies (active immunization) or passive transfer of the anti-Ro positive maternal IgG into pregnant mice (passive immunization). Altogether, anti-Ro autoantibodies' inhibition of Ca channels are causally related to the development of CHB, but the low incidence of CHB children born to anti-Ro antibodies positive mothers suggest that additional factor(s) may be necessary to contribute to the full spectrum of CHB.</p>
</sec>
<sec>
<title>Anti-ro Antibody Positive IgG Inhibits Ca Currents by Binding Directly to the Pore Forming Subunit of the Ca Channels</title>
<p>As pointed out earlier, anti-Ro antibody positive IgG cannot cross the sarcolemma of a normal fetal cardiac myocyte, and hence one can suspect that its effects are not directly mediated through its antigen, SSA/Ro, but rather via sarcolemma targets such as Ca channels. Evidence for direct interaction between anti-Ro antibodies and Ca channels is provided by the direct binding of anti-Ro antibodies on the pore forming α<sub>1</sub> subunit of VGCC, resulting in inhibition of I<sub>CaL</sub>. Indeed, using immunostaining and Western blots, it was demonstrated that anti-Ro antibody positive IgG binds directly to the Ca channels' α<sub>1</sub> subunit (<xref ref-type="bibr" rid="B99">99</xref>, <xref ref-type="bibr" rid="B107">107</xref>). In a subsequent study, purified GST fusion proteins corresponding to the extracellular loop S5–S6 of each of the four domains that form the pore of the α<sub>1D</sub> subunit were expressed and their reactivity to anti-Ro antibody positive IgG was tested. Fourteen percent of anti-Ro antibody positive IgG reacted specifically with the extracellular loop S5-S6 of the first domains of the α<sub>1D</sub> subunit, as demonstrated by both ELISA and Western blots (<xref ref-type="bibr" rid="B108">108</xref>). L-type Ca channels' inhibition by anti-Ro antibodies is one of the mechanisms for the electrocardiographic abnormalities seen in CHB. The resulting formulation of the “Ca channel hypothesis” was based on the above experimental findings and was driven by the fact that AVN electrogenesis depends on the L-type Ca channels. Inhibition of this channel will ultimately lead to AVB, as seen in CHB. The “Ca channel hypothesis” states that circulating maternal antibodies directly cross react with L-type Ca channel pore forming protein α<sub>1</sub>-subunit, inhibiting the currents and leading to the development of AVB (<xref ref-type="bibr" rid="B97">97</xref>).</p>
</sec>
</sec>
<sec>
<title>T-type Ca Channel and Autoimmune-Associated Congenital Heart Block</title>
<p>T-type α<sub>1G</sub> VGCCs subtype participates with α<sub>1H</sub> in regulating electrical conduction through the AVN (<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B31">31</xref>, <xref ref-type="bibr" rid="B34">34</xref>). α<sub>1G</sub> VGCC is highly expressed in the AVN in human hearts (<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B31">31</xref>, <xref ref-type="bibr" rid="B32">32</xref>). Homozygous α<sub>1G</sub> knockout mice exhibit first-degree AVB and bradycardia, a phenotype seen in CHB (<xref ref-type="bibr" rid="B25">25</xref>). These findings suggest α<sub>1G</sub> VGCC as an additional potential cross-reactive target with anti-Ro antibody positive IgG in the development of CHB. Hu et al. demonstrated that anti-Ro antibody positive IgG decreased both I<sub>CaL</sub> and T-type Ca current (I<sub>Ca−T</sub>) without affecting the delayed rectifier K current, I<sub>K</sub>, and the funny current, I<sub>f</sub>, in rabbit SAN cells (<xref ref-type="bibr" rid="B98">98</xref>). The average inhibition of I<sub>Ca−T</sub> by anti-Ro antibody positive IgG was 31.4% at −40 mV and 44.1% at −20 mV in rabbit SAN cells (<xref ref-type="bibr" rid="B98">98</xref>). In addition, although anti-Ro antibody positive IgG inhibited the α<sub>1H</sub> I<sub>CaT</sub> expressed in the Xenopus oocyte (<xref ref-type="bibr" rid="B100">100</xref>), α<sub>1H</sub> Ca channel knockout mice have no ECG changes (<xref ref-type="bibr" rid="B109">109</xref>), likely secondary to the low level of α<sub>1H</sub> expression in the human neonatal AVN cells (<xref ref-type="bibr" rid="B107">107</xref>). These findings support the conclusion that the α<sub>1G</sub> Ca channel is the target for anti-Ro antibody positive IgG. Strindberg et al. demonstrated α<sub>1G</sub> mRNA and proteins in human fetal hearts and that α<sub>1G</sub> I<sub>Ca−T</sub> rather than α<sub>1H</sub> I<sub>Ca−T</sub> is the dominant current in the AVN in newborns (<xref ref-type="bibr" rid="B107">107</xref>). Experimental data using immunoprecipitation, Western blot and immunofluorescent staining have demonstrated accessibility of anti-Ro antibody positive IgG to the α<sub>1G</sub> epitope on the surfaces on the cardiomyocytes in the human fetal heart (<xref ref-type="bibr" rid="B107">107</xref>). Reactivity to α<sub>1G</sub> T-type VGCC was significantly higher in CHB maternal sera compared to controls. Binding epitope of anti-Ro antibody positive IgG was mapped to the extracellular S5–S6 portion of repeat I of α<sub>1G</sub> subunit (aa305–319; designated as p305). Using the patch-clamp technique, the authors also demonstrated that anti-Ro antibody positive IgG inhibited I<sub>Ca−T</sub> in isolated mice SAN cells (<xref ref-type="bibr" rid="B107">107</xref>). Taken together, these results indicate that anti-Ro antibody positive IgG readily target an extracellular epitope of α<sub>1G</sub> T-type VGCC and inhibit the current in human fetal cardiomyocytes, thus contributing to the development of AVB as seen in CHB.</p>
<p>Anti-52kD Ro antibodies are present in 80% of mothers of children with CHB; however, the risk of having CHB children is low, with only 1–2% in single anti-Ro antibody positive pregnancies (<xref ref-type="bibr" rid="B84">84</xref>). Markham et al. investigated if reactivity with p305 (anti-Ro/p305) can be used clinically to more accurately predict CHB in anti-Ro antibody positive patients (<xref ref-type="bibr" rid="B110">110</xref>). Using anti-Ro antibody positive IgG and with multiple control groups, reactivity was determined and compared for binding to anti-Ro/p305. In mothers carrying anti-Ro antibodies, positive anti-Ro/p305 antibodies were detected in 3/59 (5%) CHB pregnancies, 4/30 (13%) unaffected pregnancies with a CHB-sibling, and 0/42 (0%) of unaffected pregnancies with no CHB-sibling. Similarly, using umbilical blood from 61 CHB and 41 healthy with CHB-sibling, in which reactivity would unambiguously substantiate exposure to maternal antibody, no association of anti-Ro/p305 with CHB was detected. These data indicate that anti-Ro/p305 reactivity in pregnant anti-Ro antibody-positive patients is not a robust maternal marker for assessing increased risk of CHB (<xref ref-type="bibr" rid="B110">110</xref>).</p>
<p>As described above, it is well-recognized that maternal anti-Ro antibody is associated with the development of the congenial AVB, at least in part resulting from an inhibitory cross-reaction with L- and T-type Ca channels. More recent, studies demonstrated that 10–60% of anti-Ro-positive subjects are at increased risk of developing QTc prolongation as a result of anti-Ro antibodies' interference with K channels, (<xref ref-type="bibr" rid="B111">111</xref>–<xref ref-type="bibr" rid="B115">115</xref>) resulting in complex ventricular arrhythmia, (<xref ref-type="bibr" rid="B116">116</xref>, <xref ref-type="bibr" rid="B117">117</xref>) including Torsade's de Pointes (TdP) (<xref ref-type="bibr" rid="B118">118</xref>, <xref ref-type="bibr" rid="B119">119</xref>). Lazzerini et al. (<xref ref-type="bibr" rid="B119">119</xref>) recently evaluated 25 consecutive patients who experienced TdP, where anti-Ro antibody was present in 15 out of 25 patients. Purified anti-Ro positive IgG from TdP patients cross-reacted with the Human Ether-a-go-go-related Gene (hERG) K channel and significantly inhibited the resulting current, IKr. This observation indicates that anti-Ro antibodies may represent a novel, clinically silent risk factors for TdP. To date, studies on the association of anti-Ro antibodies and atrial fibrillation are scarce. In our previous study (<xref ref-type="bibr" rid="B120">120</xref>), we were able to induce atrial fibrillation in the α<sub>1D</sub> knockout mice but not in the wild-type mice. One can speculate that the unique atrial specific distribution of α<sub>1D</sub> Ca channel, together with the documented inhibitory effect of the anti-Ro antibodies on the α<sub>1D</sub> Ca channels, may suggest that anti-Ro positive patients might be at increased risk of having atrial fibrillation, warranting further investigations.</p>
</sec>
</sec>
<sec id="s4">
<title>Conclusions and Future Directions</title>
<p>Cardiac Ca channels, including both L- and T-type Ca channels, play critical roles in the impulse generation in the SAN, the conduction through the AVN and the development of arrhythmias. Autoantibodies targeting Ca channels have been identified in 2 major pathologies, DCM and CHB. In addition, several autoantibodies are directly related to sudden death in patients with DCM, including anti-N/K-ATPase, anti-M2 muscarinic acetylcholine receptors, and anti-β1 receptor antibodies, indirectly affecting the L-type VGCCs. Early risk stratification to effectively prevent adverse outcomes in DCM has been challenging. Recent studies confirmed the presence of autoantibodies directly against Ca channel α<sub>1C</sub> subunit in DCM, which was identified as a strong predictor for ventricular arrhythmias and sudden cardiac death, indicating that anti-α<sub>1C</sub> Ca channel antibodies might be a valuable biomarker to predict sudden death in DCM.</p>
<p>The association of anti-Ro autoantibodies with CHB is generally accepted, but the predictive value of these autoantibodies is still low despite overwhelming experimental data demonstrating causality between anti-Ro antibodies and electrocardiographic abnormalities seen in CHB (<xref ref-type="fig" rid="F2">Figure 2</xref>). This indicates that anti-Ro antibodies are necessary, but not sufficient, for inducing the clinical electrocardiographic phenotype. To date, two hypotheses have been proposed to explain the molecular mechanism(s) by which maternal anti-Ro antibodies lead to the development of CHB in the fetal hearts (<xref ref-type="bibr" rid="B79">79</xref>, <xref ref-type="bibr" rid="B121">121</xref>). The “apoptosis hypothesis” (<xref ref-type="fig" rid="F3">Figure 3</xref>) suggests that intracellular antigens translocate to the surface of cardiomyocytes undergoing apoptosis during physiological remodeling, thereby exposing the antigens to the circulating maternal anti-Ro antibodies. Binding of anti-Ro antibodies to the cell surface antigens promotes pro-inflammatory and pro-fibrotic responses (<xref ref-type="bibr" rid="B122">122</xref>, <xref ref-type="bibr" rid="B123">123</xref>), causing the fibrosis of the AVN, which eventually leads to the development of the irreversible AVB (<xref ref-type="bibr" rid="B124">124</xref>, <xref ref-type="bibr" rid="B125">125</xref>). The “Ca channel hypothesis” explained in this review is based on molecular mimicry, whereby anti-Ro antibodies directly cross-react and subsequently inhibit the cardiac Ca channels' activity, thereby causing sinus bradycardia and AVB (<xref ref-type="bibr" rid="B77">77</xref>, <xref ref-type="bibr" rid="B78">78</xref>, <xref ref-type="bibr" rid="B108">108</xref>) (<xref ref-type="fig" rid="F4">Figure 4</xref>). This occurs by anti-Ro autoantibodies binding to Ca channels and the resulting inhibition of I<sub>CaL</sub> (Acute effect, <xref ref-type="fig" rid="F4">Figure 4</xref>). The subsequent cross-linkage and downregulation of Ca channels and lysis by lysosomes followed by intracellular Ca dysregulation leads to cell death/apoptosis, inflammation, and fibrosis of the AVN (<xref ref-type="fig" rid="F4">Figure 4</xref>). The ultimate proof of direct autoantibodies' involvement in CHB is provided by the identification of the site of action on the different subunits of cardiac Ca channels (<xref ref-type="bibr" rid="B126">126</xref>–<xref ref-type="bibr" rid="B128">128</xref>), including α<sub>1C</sub> and α<sub>1D</sub> subunits of L-type VGCCs and α<sub>1G</sub> subunit of T-type VGCCs (<xref ref-type="fig" rid="F4">Figure 4</xref>). Although autoantibodies are utilized as diagnostic or prognostic markers in other pathologies, unfortunately, to date, there is no specific maternal marker for assessing the increased risk of having CHB children during an anti-Ro positive pregnancy. It is possible that, instead of having a single CHB-inducing antibody specificity, future studies may focus on several different specificities that may act synergistically to induce AVB in fetal hearts.</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption>
<p>Schematic representation of alternative mechanism of linking anti-Ro antibodies to the development of atrioventricular block: fetal cardiomyocytes undergoing “physiological” apoptosis cause the surface translocation of the intracellular located Ro antigens. Circulating maternal anti-Ro antibodies which can cross the placenta, subsequently bind to the translocated Ro antigens at the cell surface; provoke the secretion of proinflammatory cytokines such as TGFβ from macrophages. Excessive TGFβ secretion activates fibroblasts leading to scars promoting myofibroblasts in the Atrioventricular node, resulting in atrioventricular block.</p>
</caption>
<graphic xlink:href="fcvm-06-00054-g0003"></graphic>
</fig>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption>
<p>Schematic illustration of the Ca channel hypothesis. Maternal anti-Ro antibodies cross react and bind to α<sub>1C</sub> (yellow), α<sub>1D</sub> (green), and α<sub>1G</sub> (red) Ca channels in the fetal human heart, inhibit all three Ca currents leading to sinus bradycardia and atrioventricular (AV) block (acute effect). Furthermore, fetal heart Ca channels are exposed <italic>chronically</italic> (chronic effect) (1) to maternal anti-Ro antibodies during pregnancy. Binding of anti-Ro antibodies to Ca channels (2), can cause cross-linking of the adjacent ion channels by the two Fab arms of IgG (3) to increase the internalization of the channel/antibody complex and thereby decrease of the channel density on the cell membrane. Internalized Ca channels are lysed by lysosomes (4). If the number of Ca channels on cell surface decreased to a critical level, then cell death will occur. Cell death, <italic>per se</italic>, could trigger inflammation subsequent to leukocytic influx resulting in damage of the surrounding healthy myocytes such as in sinoatrial node and AV node which can cause permanent sinus bradycardia and AV block.</p>
</caption>
<graphic xlink:href="fcvm-06-00054-g0004"></graphic>
</fig>
<p>Peptide-based therapeutic approaches are one of the growing classes of novel therapeutic agents. The development of short non-immunogenic peptides and their use as decoy targets for pathogenic autoantibodies is expected to minimize and/or prevent autoantibody association with ion channels and their functions. This therapeutic path awaits further development and progress.</p>
</sec>
<sec id="s5">
<title>Author Contributions</title>
<p>All authors listed have made a substantial, direct and intellectual contribution to the work, and approved it for publication.</p>
<sec>
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rougier</surname><given-names>JS</given-names></name><name><surname>Abriel</surname><given-names>H</given-names></name></person-group>. <article-title>Cardiac voltage-gated calcium channel macromolecular complexes</article-title>. <source/>Biochim Biophys Acta. (<year>2016</year>) <volume>1863</volume>:<fpage>1806</fpage>–<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamcr.2015.12.014</pub-id><pub-id pub-id-type="pmid">26707467</pub-id></mixed-citation>
</ref>
<ref id="B2">
<label>2.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Betzenhauser</surname><given-names>MJ</given-names></name><name><surname>Pitt</surname><given-names>GS</given-names></name><name><surname>Antzelevitch</surname><given-names>C</given-names></name></person-group>. <article-title>Calcium channel mutations in cardiac arrhythmia syndromes</article-title>. <source/>Curr Mol Pharmacol. (<year>2015</year>) <volume>8</volume>:<fpage>133</fpage>–<lpage>42</lpage>. <pub-id pub-id-type="doi">10.2174/1874467208666150518114857</pub-id><pub-id pub-id-type="pmid">25981977</pub-id></mixed-citation>
</ref>
<ref id="B3">
<label>3.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dolphin</surname><given-names>AC</given-names></name></person-group>. <article-title>Calcium channel diversity: multiple roles of calcium channel subunits</article-title>. <source/>Curr Opin Neurobiol. (<year>2009</year>) <volume>19</volume>:<fpage>237</fpage>–<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1016/j.conb.2009.06.006</pub-id><pub-id pub-id-type="pmid">19559597</pub-id></mixed-citation>
</ref>
<ref id="B4">
<label>4.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Catterall</surname><given-names>WA</given-names></name></person-group>. <article-title>Signaling complexes of voltage-gated sodium and calcium channels</article-title>. <source/>Neurosci Lett. (<year>2010</year>) <volume>486</volume>:<fpage>107</fpage>–<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2010.08.085</pub-id><pub-id pub-id-type="pmid">20816922</pub-id></mixed-citation>
</ref>
<ref id="B5">
<label>5.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mesirca</surname><given-names>P</given-names></name><name><surname>Torrente</surname><given-names>AG</given-names></name><name><surname>Mangoni</surname><given-names>ME</given-names></name></person-group>. <article-title>Functional role of voltage gated Ca(2+) channels in heart automaticity</article-title>. <source/>Front Physiol. (<year>2015</year>) <volume>6</volume>:<fpage>19</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2015.00019</pub-id><pub-id pub-id-type="pmid">25698974</pub-id></mixed-citation>
</ref>
<ref id="B6">
<label>6.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zamponi</surname><given-names>GW</given-names></name><name><surname>Striessnig</surname><given-names>J</given-names></name><name><surname>Koschak</surname><given-names>A</given-names></name><name><surname>Dolphin</surname><given-names>AC</given-names></name></person-group>. <article-title>The physiology, pathology, and pharmacology of voltage-gated calcium channels and their future therapeutic potential</article-title>. <source/>Pharmacol Rev. (<year>2015</year>) <volume>67</volume>:<fpage>821</fpage>–<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1124/pr.114.009654</pub-id><pub-id pub-id-type="pmid">26362469</pub-id></mixed-citation>
</ref>
<ref id="B7">
<label>7.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Qin</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name></person-group>. <article-title>Mutations in voltage-gated L-type calcium channel: implications in cardiac arrhythmia</article-title>. <source/>Channels. (<year>2018</year>) <volume>12</volume>:<fpage>201</fpage>–<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1080/19336950.2018.1499368</pub-id><pub-id pub-id-type="pmid">30027834</pub-id></mixed-citation>
</ref>
<ref id="B8">
<label>8.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venetucci</surname><given-names>L</given-names></name><name><surname>Denegri</surname><given-names>M</given-names></name><name><surname>Napolitano</surname><given-names>C</given-names></name><name><surname>Priori</surname><given-names>SG</given-names></name></person-group>. <article-title>Inherited calcium channelopathies in the pathophysiology of arrhythmias</article-title>. <source/>Nat Rev Cardiol. (<year>2012</year>) <volume>9</volume>:<fpage>561</fpage>–<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1038/nrcardio.2012.93</pub-id><pub-id pub-id-type="pmid">22733215</pub-id></mixed-citation>
</ref>
<ref id="B9">
<label>9.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>HC</given-names></name><name><surname>Huang</surname><given-names>KT</given-names></name><name><surname>Wang</surname><given-names>XL</given-names></name><name><surname>Shen</surname><given-names>WK</given-names></name></person-group>. <article-title>Autoantibodies and cardiac arrhythmias</article-title>. <source/>Heart Rhythm. (<year>2011</year>) <volume>8</volume>:<fpage>1788</fpage>–<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1016/j.hrthm.2011.06.032</pub-id><pub-id pub-id-type="pmid">21740882</pub-id></mixed-citation>
</ref>
<ref id="B10">
<label>10.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lazzerini</surname><given-names>PE</given-names></name><name><surname>Capecchi</surname><given-names>PL</given-names></name><name><surname>Laghi-Pasini</surname><given-names>F</given-names></name><name><surname>Boutjdir</surname><given-names>M</given-names></name></person-group>. <article-title>Autoimmune cardiac channelopathies: the heart of the matter</article-title>. <source/>Nat Rev Cardiol. (<year>2017</year>) <volume>14</volume>:<fpage>566</fpage>. <pub-id pub-id-type="doi">10.1038/nrcardio.2017.111</pub-id><pub-id pub-id-type="pmid">28726851</pub-id></mixed-citation>
</ref>
<ref id="B11">
<label>11.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Du</surname><given-names>Y</given-names></name><name><surname>Yuan</surname><given-names>J</given-names></name><name><surname>Cheng</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><etal></etal></person-group>. <article-title>Arrhythmogenic autoantibodies against calcium channel lead to sudden death in idiopathic dilated cardiomyopathy</article-title>. <source/>Eur J Heart Fail. (<year>2011</year>) <volume>13</volume>:<fpage>264</fpage>–<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1093/eurjhf/hfq198</pub-id><pub-id pub-id-type="pmid">21044990</pub-id></mixed-citation>
</ref>
<ref id="B12">
<label>12.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durante</surname><given-names>A</given-names></name><name><surname>Bronzato</surname><given-names>S</given-names></name></person-group>. <article-title>The increased cardiovascular risk in patients affected by autoimmune diseases: review of the various manifestations</article-title>. <source/>J Clin Med Res. (<year>2015</year>) <volume>7</volume>:<fpage>379</fpage>–<lpage>84</lpage>. <pub-id pub-id-type="doi">10.14740/jocmr2122w</pub-id><pub-id pub-id-type="pmid">25883699</pub-id></mixed-citation>
</ref>
<ref id="B13">
<label>13.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nilius</surname><given-names>B</given-names></name><name><surname>Hess</surname><given-names>P</given-names></name><name><surname>Lansman</surname><given-names>JB</given-names></name><name><surname>Tsien</surname><given-names>RW</given-names></name></person-group>. <article-title>A novel type of cardiac calcium channel in ventricular cells</article-title>. <source/>Nature. (<year>1985</year>) <volume>316</volume>:<fpage>443</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1038/316443a0</pub-id><pub-id pub-id-type="pmid">2410797</pub-id></mixed-citation>
</ref>
<ref id="B14">
<label>14.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bean</surname><given-names>BP</given-names></name></person-group>. <article-title>Two kinds of calcium channels in canine atrial cells. differences in kinetics, selectivity, and pharmacology</article-title>. <source/>J Gen Physiol. (<year>1985</year>) <volume>86</volume>:<fpage>1</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1085/jgp.86.1.1</pub-id><pub-id pub-id-type="pmid">2411846</pub-id></mixed-citation>
</ref>
<ref id="B15">
<label>15.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Catterall</surname><given-names>WA</given-names></name></person-group>. <article-title>Voltage-gated calcium channels</article-title>. <source/>Cold Spring Harb Perspect Biol. (<year>2011</year>) <volume>3</volume>:<fpage>a003947</fpage>. <pub-id pub-id-type="doi">10.1101/cshperspect.a003947</pub-id><pub-id pub-id-type="pmid">21746798</pub-id></mixed-citation>
</ref>
<ref id="B16">
<label>16.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dolphin</surname><given-names>AC</given-names></name></person-group>. <article-title>Voltage-gated calcium channels and their auxiliary subunits: physiology and pathophysiology and pharmacology</article-title>. <source/>J Physiol. (<year>2016</year>) <volume>594</volume>:<fpage>5369</fpage>–<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1113/JP272262</pub-id><pub-id pub-id-type="pmid">27273705</pub-id></mixed-citation>
</ref>
<ref id="B17">
<label>17.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perez-Reyes</surname><given-names>E</given-names></name></person-group>. <article-title>Molecular physiology of low-voltage-activated t-type calcium channels</article-title>. <source/>Physiol Rev. (<year>2003</year>) <volume>83</volume>:<fpage>117</fpage>–<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.00018.2002</pub-id><pub-id pub-id-type="pmid">12506128</pub-id></mixed-citation>
</ref>
<ref id="B18">
<label>18.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cribbs</surname><given-names>L</given-names></name></person-group>. <article-title>T-type calcium channel expression and function in the diseased heart</article-title>. <source/>Channels. (<year>2010</year>) <volume>4</volume>:<fpage>447</fpage>–<lpage>52</lpage>. <pub-id pub-id-type="doi">10.4161/chan.4.6.12870</pub-id><pub-id pub-id-type="pmid">21139421</pub-id></mixed-citation>
</ref>
<ref id="B19">
<label>19.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nowycky</surname><given-names>MC</given-names></name><name><surname>Fox</surname><given-names>AP</given-names></name><name><surname>Tsien</surname><given-names>RW</given-names></name></person-group>. <article-title>Three types of neuronal calcium channel with different calcium agonist sensitivity</article-title>. <source/>Nature. (<year>1985</year>) <volume>316</volume>:<fpage>440</fpage>–<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1038/316440a0</pub-id><pub-id pub-id-type="pmid">2410796</pub-id></mixed-citation>
</ref>
<ref id="B20">
<label>20.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mintz</surname><given-names>IM</given-names></name><name><surname>Adams</surname><given-names>ME</given-names></name><name><surname>Bean</surname><given-names>BP</given-names></name></person-group>. <article-title>P-type calcium channels in rat central and peripheral neurons</article-title>. <source/>Neuron. (<year>1992</year>) <volume>9</volume>:<fpage>85</fpage>–<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1016/0896-6273(92)90223-Z</pub-id><pub-id pub-id-type="pmid">1321648</pub-id></mixed-citation>
</ref>
<ref id="B21">
<label>21.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Namkung</surname><given-names>Y</given-names></name><name><surname>Smith</surname><given-names>SM</given-names></name><name><surname>Lee</surname><given-names>SB</given-names></name><name><surname>Skrypnyk</surname><given-names>NV</given-names></name><name><surname>Kim</surname><given-names>HL</given-names></name><name><surname>Chin</surname><given-names>H</given-names></name><etal></etal></person-group>. <article-title>Targeted disruption of the Ca2+ channel beta3 subunit reduces N- and L-type Ca2+ channel activity and alters the voltage-dependent activation of P/Q-type Ca2+ channels in neurons</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A. (<year>1998</year>) <volume>95</volume>:<fpage>12010</fpage>–<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.95.20.12010</pub-id><pub-id pub-id-type="pmid">9751781</pub-id></mixed-citation>
</ref>
<ref id="B22">
<label>22.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lambert</surname><given-names>RC</given-names></name><name><surname>McKenna</surname><given-names>F</given-names></name><name><surname>Maulet</surname><given-names>Y</given-names></name><name><surname>Talley</surname><given-names>EM</given-names></name><name><surname>Bayliss</surname><given-names>DA</given-names></name><name><surname>Cribbs</surname><given-names>LL</given-names></name><etal></etal></person-group>. <article-title>Low-voltage-activated Ca2+ currents are generated by members of the CavT subunit family (alpha1G/H) in rat primary sensory neurons</article-title>. <source/>J Neurosci. (<year>1998</year>) <volume>18</volume>:<fpage>8605</fpage>–<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.18-21-08605.1998</pub-id><pub-id pub-id-type="pmid">9786968</pub-id></mixed-citation>
</ref>
<ref id="B23">
<label>23.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perez-Reyes</surname><given-names>E</given-names></name><name><surname>Cribbs</surname><given-names>LL</given-names></name><name><surname>Daud</surname><given-names>A</given-names></name><name><surname>Lacerda</surname><given-names>AE</given-names></name><name><surname>Barclay</surname><given-names>J</given-names></name><name><surname>Williamson</surname><given-names>MP</given-names></name><etal></etal></person-group>. <article-title>Molecular characterization of a neuronal low-voltage-activated T-type calcium channel</article-title>. <source/>Nature. (<year>1998</year>) <volume>391</volume>:<fpage>896</fpage>–<lpage>900</lpage>. <pub-id pub-id-type="doi">10.1038/36110</pub-id><pub-id pub-id-type="pmid">9495342</pub-id></mixed-citation>
</ref>
<ref id="B24">
<label>24.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cribbs</surname><given-names>LL</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Satin</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Daud</surname><given-names>A</given-names></name><etal></etal></person-group>. <article-title>Cloning and characterization of alpha1H from human heart, a member of the T-type Ca2+ channel gene family</article-title>. <source/>Circ Res. (<year>1998</year>) <volume>83</volume>:<fpage>103</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.83.1.103</pub-id><pub-id pub-id-type="pmid">9670923</pub-id></mixed-citation>
</ref>
<ref id="B25">
<label>25.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mangoni</surname><given-names>ME</given-names></name><name><surname>Traboulsie</surname><given-names>A</given-names></name><name><surname>Leoni</surname><given-names>AL</given-names></name><name><surname>Couette</surname><given-names>B</given-names></name><name><surname>Marger</surname><given-names>L</given-names></name><name><surname>Le Quang</surname><given-names>K</given-names></name><etal></etal></person-group>. <article-title>Bradycardia and slowing of the atrioventricular conduction in mice lacking CaV3.1/alpha1G T-type calcium channels</article-title>. <source/>Circ Res. (<year>2006</year>) <volume>98</volume>:<fpage>1422</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.0000225862.14314.49</pub-id><pub-id pub-id-type="pmid">16690884</pub-id></mixed-citation>
</ref>
<ref id="B26">
<label>26.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizuta</surname><given-names>E</given-names></name><name><surname>Shirai</surname><given-names>M</given-names></name><name><surname>Arakawa</surname><given-names>K</given-names></name><name><surname>Hidaka</surname><given-names>K</given-names></name><name><surname>Miake</surname><given-names>J</given-names></name><name><surname>Ninomiya</surname><given-names>H</given-names></name><etal></etal></person-group>. <article-title>Different distribution of Cav3</article-title>.2 and Cav3.1 transcripts encoding T-type Ca(2+) channels in the embryonic heart of mice. <source/>Biomed Res. (<year>2010</year>) <volume>31</volume>:<fpage>301</fpage>–<lpage>5</lpage>. <pub-id pub-id-type="doi">10.2220/biomedres.31.301</pub-id><pub-id pub-id-type="pmid">21079360</pub-id></mixed-citation>
</ref>
<ref id="B27">
<label>27.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monteil</surname><given-names>A</given-names></name><name><surname>Chemin</surname><given-names>J</given-names></name><name><surname>Bourinet</surname><given-names>E</given-names></name><name><surname>Mennessier</surname><given-names>G</given-names></name><name><surname>Lory</surname><given-names>P</given-names></name><name><surname>Nargeot</surname><given-names>J</given-names></name></person-group>. <article-title>Molecular and functional properties of the human alpha(1G) subunit that forms T-type calcium channels</article-title>. <source/>J Biol Chem. (<year>2000</year>) <volume>275</volume>:<fpage>6090</fpage>–<lpage>100</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.275.9.6090</pub-id><pub-id pub-id-type="pmid">10692398</pub-id></mixed-citation>
</ref>
<ref id="B28">
<label>28.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koschak</surname><given-names>A</given-names></name><name><surname>Reimer</surname><given-names>D</given-names></name><name><surname>Huber</surname><given-names>I</given-names></name><name><surname>Grabner</surname><given-names>M</given-names></name><name><surname>Glossmann</surname><given-names>H</given-names></name><name><surname>Engel</surname><given-names>J</given-names></name><etal></etal></person-group>. <article-title>alpha 1D (Cav1</article-title>.3) subunits can form l-type Ca2+ channels activating at negative voltages. <source/>J Biol Chem. (<year>2001</year>) <volume>276</volume>:<fpage>22100</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M101469200</pub-id><pub-id pub-id-type="pmid">11285265</pub-id></mixed-citation>
</ref>
<ref id="B29">
<label>29.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baig</surname><given-names>SM</given-names></name><name><surname>Koschak</surname><given-names>A</given-names></name><name><surname>Lieb</surname><given-names>A</given-names></name><name><surname>Gebhart</surname><given-names>M</given-names></name><name><surname>Dafinger</surname><given-names>C</given-names></name><name><surname>Nurnberg</surname><given-names>G</given-names></name><etal></etal></person-group>. <article-title>Loss of Ca(v)1</article-title>.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness. <source/>Nat Neurosci. (<year>2011</year>) <volume>14</volume>:<fpage>77</fpage>–<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1038/nn.2694</pub-id><pub-id pub-id-type="pmid">21131953</pub-id></mixed-citation>
</ref>
<ref id="B30">
<label>30.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ono</surname><given-names>K</given-names></name><name><surname>Iijima</surname><given-names>T</given-names></name></person-group>. <article-title>Pathophysiological significance of T-type Ca2+ channels: properties and functional roles of T-type Ca2+ channels in cardiac pacemaking</article-title>. <source/>J Pharmacol Sci. (<year>2005</year>) <volume>99</volume>:<fpage>197</fpage>–<lpage>204</lpage>. <pub-id pub-id-type="doi">10.1254/jphs.FMJ05002X2</pub-id><pub-id pub-id-type="pmid">16272791</pub-id></mixed-citation>
</ref>
<ref id="B31">
<label>31.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vassort</surname><given-names>G</given-names></name><name><surname>Talavera</surname><given-names>K</given-names></name><name><surname>Alvarez</surname><given-names>JL</given-names></name></person-group>. <article-title>Role of T-type Ca2+ channels in the heart</article-title>. <source/>Cell Calcium. (<year>2006</year>) <volume>40</volume>:<fpage>205</fpage>–<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1016/j.ceca.2006.04.025</pub-id><pub-id pub-id-type="pmid">16766028</pub-id></mixed-citation>
</ref>
<ref id="B32">
<label>32.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferron</surname><given-names>L</given-names></name><name><surname>Capuano</surname><given-names>V</given-names></name><name><surname>Deroubaix</surname><given-names>E</given-names></name><name><surname>Coulombe</surname><given-names>A</given-names></name><name><surname>Renaud</surname><given-names>JF</given-names></name></person-group>. <article-title>Functional and molecular characterization of a T-type Ca(2+) channel during fetal and postnatal rat heart development</article-title>. <source/>J Mol Cell Cardiol. (<year>2002</year>) <volume>34</volume>:<fpage>533</fpage>–<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1006/jmcc.2002.1535</pub-id><pub-id pub-id-type="pmid">12056857</pub-id></mixed-citation>
</ref>
<ref id="B33">
<label>33.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bohn</surname><given-names>G</given-names></name><name><surname>Moosmang</surname><given-names>S</given-names></name><name><surname>Conrad</surname><given-names>H</given-names></name><name><surname>Ludwig</surname><given-names>A</given-names></name><name><surname>Hofmann</surname><given-names>F</given-names></name><name><surname>Klugbauer</surname><given-names>N</given-names></name></person-group>. <article-title>Expression of T- and L-type calcium channel mRNA in murine sinoatrial node</article-title>. <source/>FEBS Lett. (<year>2000</year>) <volume>481</volume>:<fpage>73</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/S0014-5793(00)01979-7</pub-id><pub-id pub-id-type="pmid">10984618</pub-id></mixed-citation>
</ref>
<ref id="B34">
<label>34.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hagiwara</surname><given-names>N</given-names></name><name><surname>Irisawa</surname><given-names>H</given-names></name><name><surname>Kameyama</surname><given-names>M</given-names></name></person-group>. <article-title>Contribution of two types of calcium currents to the pacemaker potentials of rabbit sino-atrial node cells</article-title>. <source/>J Physiol. (<year>1988</year>) <volume>395</volume>:<fpage>233</fpage>–<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.1988.sp016916</pub-id><pub-id pub-id-type="pmid">2457676</pub-id></mixed-citation>
</ref>
<ref id="B35">
<label>35.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benitah</surname><given-names>JP</given-names></name><name><surname>Gomez</surname><given-names>AM</given-names></name><name><surname>Fauconnier</surname><given-names>J</given-names></name><name><surname>Kerfant</surname><given-names>BG</given-names></name><name><surname>Perrier</surname><given-names>E</given-names></name><name><surname>Vassort</surname><given-names>G</given-names></name><etal></etal></person-group>. <article-title>Voltage-gated Ca2+ currents in the human pathophysiologic heart: a review</article-title>. <source/>Basic Res Cardiol. (<year>2002</year>) <volume>97</volume> (<issue>Suppl. 1</issue>):<fpage>I11</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1007/s003950200023</pub-id><pub-id pub-id-type="pmid">12479228</pub-id></mixed-citation>
</ref>
<ref id="B36">
<label>36.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Striessnig</surname><given-names>J</given-names></name><name><surname>Pinggera</surname><given-names>A</given-names></name><name><surname>Kaur</surname><given-names>G</given-names></name><name><surname>Bock</surname><given-names>G</given-names></name><name><surname>Tuluc</surname><given-names>P</given-names></name></person-group>
<article-title>L-type Ca(2+) channels in heart and brain</article-title>. <source/>Wiley Interdiscip Rev Membr Transp Signal. (<year>2014</year>) <volume>3</volume>:<fpage>15</fpage>–<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1002/wmts.102</pub-id><pub-id pub-id-type="pmid">24683526</pub-id></mixed-citation>
</ref>
<ref id="B37">
<label>37.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinggera</surname><given-names>A</given-names></name><name><surname>Lieb</surname><given-names>A</given-names></name><name><surname>Benedetti</surname><given-names>B</given-names></name><name><surname>Lampert</surname><given-names>M</given-names></name><name><surname>Monteleone</surname><given-names>S</given-names></name><name><surname>Liedl</surname><given-names>KR</given-names></name><etal></etal></person-group>. <article-title>CACNA1D <italic>de novo</italic> mutations in autism spectrum disorders activate Cav1.3 L-type calcium channels</article-title>. <source/>Biol Psychiatry. (<year>2015</year>) <volume>77</volume>:<fpage>816</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2014.11.020</pub-id><pub-id pub-id-type="pmid">25620733</pub-id></mixed-citation>
</ref>
<ref id="B38">
<label>38.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srivastava</surname><given-names>U</given-names></name><name><surname>Aromolaran</surname><given-names>AS</given-names></name><name><surname>Fabris</surname><given-names>F</given-names></name><name><surname>Lazaro</surname><given-names>D</given-names></name><name><surname>Kassotis</surname><given-names>J</given-names></name><name><surname>Qu</surname><given-names>Y</given-names></name><etal></etal></person-group>. <article-title>Novel function of alpha1D L-type calcium channel in the atria</article-title>. <source/>Biochem Biophys Res Commun. (<year>2017</year>) <volume>482</volume>:<fpage>771</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2016.11.109</pub-id><pub-id pub-id-type="pmid">27884747</pub-id></mixed-citation>
</ref>
<ref id="B39">
<label>39.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qu</surname><given-names>Y</given-names></name><name><surname>Karnabi</surname><given-names>E</given-names></name><name><surname>Ramadan</surname><given-names>O</given-names></name><name><surname>Yue</surname><given-names>Y</given-names></name><name><surname>Chahine</surname><given-names>M</given-names></name><name><surname>Boutjdir</surname><given-names>M</given-names></name></person-group>. <article-title>Perinatal and postnatal expression of Cav1</article-title>.3 alpha1D Ca(2)(+) channel in the rat heart. <source/>Pediatr Res. (<year>2011</year>) <volume>69</volume>:<fpage>479</fpage>–<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1203/PDR.0b013e318217a0df</pub-id><pub-id pub-id-type="pmid">21378599</pub-id></mixed-citation>
</ref>
<ref id="B40">
<label>40.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qu</surname><given-names>Y</given-names></name><name><surname>Baroudi</surname><given-names>G</given-names></name><name><surname>Yue</surname><given-names>Y</given-names></name><name><surname>Boutjdir</surname><given-names>M</given-names></name></person-group>. <article-title>Novel molecular mechanism involving alpha1D (Cav1</article-title>.3) L-type calcium channel in autoimmune-associated sinus bradycardia. <source/>Circulation. (<year>2005</year>) <volume>111</volume>:<fpage>3034</fpage>–<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.104.517326</pub-id><pub-id pub-id-type="pmid">15939813</pub-id></mixed-citation>
</ref>
<ref id="B41">
<label>41.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marionneau</surname><given-names>C</given-names></name><name><surname>Couette</surname><given-names>B</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Mangoni</surname><given-names>ME</given-names></name><name><surname>Nargeot</surname><given-names>J</given-names></name><etal></etal></person-group>. <article-title>Specific pattern of ionic channel gene expression associated with pacemaker activity in the mouse heart</article-title>. <source/>J Physiol. (<year>2005</year>) <volume>562</volume>:<fpage>223</fpage>–<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2004.074047</pub-id><pub-id pub-id-type="pmid">15498808</pub-id></mixed-citation>
</ref>
<ref id="B42">
<label>42.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Platzer</surname><given-names>J</given-names></name><name><surname>Engel</surname><given-names>J</given-names></name><name><surname>Schrott-Fischer</surname><given-names>A</given-names></name><name><surname>Stephan</surname><given-names>K</given-names></name><name><surname>Bova</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><etal></etal></person-group>. <article-title>Congenital deafness and sinoatrial node dysfunction in mice lacking class D L-type Ca2+ channels</article-title>. <source/>Cell. (<year>2000</year>) <volume>102</volume>:<fpage>89</fpage>–<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1016/S0092-8674(00)00013-1</pub-id><pub-id pub-id-type="pmid">10929716</pub-id></mixed-citation>
</ref>
<ref id="B43">
<label>43.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Striessnig</surname><given-names>J</given-names></name><name><surname>Koschak</surname><given-names>A</given-names></name></person-group>. <article-title>Exploring the function and pharmacotherapeutic potential of voltage-gated Ca2+ channels with gene knockout models</article-title>. <source/>Channels. (<year>2008</year>) <volume>2</volume>:<fpage>233</fpage>–<lpage>51</lpage>. <pub-id pub-id-type="doi">10.4161/chan.2.4.5847</pub-id><pub-id pub-id-type="pmid">18719397</pub-id></mixed-citation>
</ref>
<ref id="B44">
<label>44.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mangoni</surname><given-names>ME</given-names></name><name><surname>Couette</surname><given-names>B</given-names></name><name><surname>Bourinet</surname><given-names>E</given-names></name><name><surname>Platzer</surname><given-names>J</given-names></name><name><surname>Reimer</surname><given-names>D</given-names></name><name><surname>Striessnig</surname><given-names>J</given-names></name><etal></etal></person-group>. <article-title>Functional role of L-type Cav1</article-title>.3 Ca2+ channels in cardiac pacemaker activity. <source/>Proc. Natl. Acad. Sci. U.S.A. (<year>2003</year>) <volume>100</volume>:<fpage>5543</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0935295100</pub-id><pub-id pub-id-type="pmid">12700358</pub-id></mixed-citation>
</ref>
<ref id="B45">
<label>45.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Daud</surname><given-names>AN</given-names></name><name><surname>Cribbs</surname><given-names>LL</given-names></name><name><surname>Lacerda</surname><given-names>AE</given-names></name><name><surname>Pereverzev</surname><given-names>A</given-names></name><name><surname>Klockner</surname><given-names>U</given-names></name><etal></etal></person-group>. <article-title>Cloning and expression of a novel member of the low voltage-activated T-type calcium channel family</article-title>. <source/>J Neurosci. (<year>1999</year>) <volume>19</volume>:<fpage>1912</fpage>–<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.19-06-01912.1999</pub-id><pub-id pub-id-type="pmid">10066244</pub-id></mixed-citation>
</ref>
<ref id="B46">
<label>46.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Catterall</surname><given-names>WA</given-names></name><name><surname>Perez-Reyes</surname><given-names>E</given-names></name><name><surname>Snutch</surname><given-names>TP</given-names></name><name><surname>Striessnig</surname><given-names>J</given-names></name></person-group>. <article-title>International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels</article-title>. <source/>Pharmacol Rev. (<year>2005</year>) <volume>57</volume>:<fpage>411</fpage>–<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1124/pr.57.4.5</pub-id><pub-id pub-id-type="pmid">16382099</pub-id></mixed-citation>
</ref>
<ref id="B47">
<label>47.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dolphin</surname><given-names>AC</given-names></name><name><surname>Wyatt</surname><given-names>CN</given-names></name><name><surname>Richards</surname><given-names>J</given-names></name><name><surname>Beattie</surname><given-names>RE</given-names></name><name><surname>Craig</surname><given-names>P</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name><etal></etal></person-group>. <article-title>The effect of alpha2-delta and other accessory subunits on expression and properties of the calcium channel alpha1G</article-title>. <source/>J Physiol. (<year>1999</year>) <volume>519</volume>:<fpage>35</fpage>–<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-7793.1999.0035o.x</pub-id><pub-id pub-id-type="pmid">10432337</pub-id></mixed-citation>
</ref>
<ref id="B48">
<label>48.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dubel</surname><given-names>SJ</given-names></name><name><surname>Altier</surname><given-names>C</given-names></name><name><surname>Chaumont</surname><given-names>S</given-names></name><name><surname>Lory</surname><given-names>P</given-names></name><name><surname>Bourinet</surname><given-names>E</given-names></name><name><surname>Nargeot</surname><given-names>J</given-names></name></person-group>. <article-title>Plasma membrane expression of T-type calcium channel alpha(1) subunits is modulated by high voltage-activated auxiliary subunits</article-title>. <source/>J Biol Chem. (<year>2004</year>) <volume>279</volume>:<fpage>29263</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M313450200</pub-id><pub-id pub-id-type="pmid">15123697</pub-id></mixed-citation>
</ref>
<ref id="B49">
<label>49.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiang</surname><given-names>CS</given-names></name><name><surname>Huang</surname><given-names>CH</given-names></name><name><surname>Chieng</surname><given-names>H</given-names></name><name><surname>Chang</surname><given-names>YT</given-names></name><name><surname>Chang</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>JJ</given-names></name><etal></etal></person-group>. <article-title>The Ca(v)3</article-title>.2 T-type Ca(2+) channel is required for pressure overload-induced cardiac hypertrophy in mice. <source/>Circ Res. (<year>2009</year>) <volume>104</volume>:<fpage>522</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.108.184051</pub-id><pub-id pub-id-type="pmid">19122177</pub-id></mixed-citation>
</ref>
<ref id="B50">
<label>50.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>DQ</given-names></name><name><surname>Zhou</surname><given-names>SS</given-names></name><name><surname>Zhao</surname><given-names>DH</given-names></name><name><surname>Sheng</surname><given-names>BH</given-names></name></person-group>. <article-title>Effects of furyl-dihydropyridine on action potential ventricular myocardium of rabbit <italic>in vivo</italic> and isolated guinea pig left atrium <italic>in vitro</italic></article-title>. <source/>Zhongguo Yao Li Xue Bao. (<year>1993</year>) <volume>14</volume>:<fpage>164</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="pmid">8352012</pub-id></mixed-citation>
</ref>
<ref id="B51">
<label>51.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirano</surname><given-names>Y</given-names></name><name><surname>Fozzard</surname><given-names>HA</given-names></name><name><surname>January</surname><given-names>CT</given-names></name></person-group>. <article-title>Characteristics of L- and T-type Ca2+ currents in canine cardiac Purkinje cells</article-title>. <source/>Am J Physiol. (<year>1989</year>) <volume>256</volume>:<fpage>H1478</fpage>–<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.1989.256.5.H1478</pub-id><pub-id pub-id-type="pmid">2470265</pub-id></mixed-citation>
</ref>
<ref id="B52">
<label>52.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tseng</surname><given-names>GN</given-names></name><name><surname>Boyden</surname><given-names>PA</given-names></name></person-group>. <article-title>Multiple types of Ca2+ currents in single canine Purkinje cells</article-title>. <source/>Circ Res. (<year>1989</year>) <volume>65</volume>:<fpage>1735</fpage>–<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.65.6.1735</pub-id><pub-id pub-id-type="pmid">2555080</pub-id></mixed-citation>
</ref>
<ref id="B53">
<label>53.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nilius</surname><given-names>B</given-names></name></person-group>. <article-title>Possible functional significance of a novel type of cardiac Ca channel</article-title>. <source/>Biomed Biochim Acta. (<year>1986</year>) <volume>45</volume>:<fpage>K37</fpage>–<lpage>45</lpage>. <pub-id pub-id-type="pmid">2430559</pub-id></mixed-citation>
</ref>
<ref id="B54">
<label>54.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nilius</surname><given-names>B</given-names></name><name><surname>Talavera</surname><given-names>K</given-names></name><name><surname>Verkhratsky</surname><given-names>A</given-names></name></person-group>. <article-title>T-type calcium channels: the never ending story</article-title>. <source/>Cell Calcium. (<year>2006</year>) <volume>40</volume>:<fpage>81</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.ceca.2006.04.011</pub-id><pub-id pub-id-type="pmid">16797069</pub-id></mixed-citation>
</ref>
<ref id="B55">
<label>55.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>YH</given-names></name><name><surname>Fu</surname><given-names>M</given-names></name></person-group>. <article-title>Autoimmunity in the pathogenesis of cardiomyopathy</article-title>. <source/>J Autoimmun. (<year>2001</year>) <volume>16</volume>:<fpage>1</fpage>–<lpage>2</lpage>. <pub-id pub-id-type="doi">10.1006/jaut.2000.0466</pub-id><pub-id pub-id-type="pmid">11221990</pub-id></mixed-citation>
</ref>
<ref id="B56">
<label>56.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacLellan</surname><given-names>WR</given-names></name><name><surname>Lusis</surname><given-names>AJ</given-names></name></person-group>. <article-title>Dilated cardiomyopathy: learning to live with yourself</article-title>. <source/>Nat Med. (<year>2003</year>) <volume>9</volume>:<fpage>1455</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1038/nm1203-1455</pub-id><pub-id pub-id-type="pmid">14647516</pub-id></mixed-citation>
</ref>
<ref id="B57">
<label>57.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jahns</surname><given-names>R</given-names></name><name><surname>Boivin</surname><given-names>V</given-names></name><name><surname>Schwarzbach</surname><given-names>V</given-names></name><name><surname>Ertl</surname><given-names>G</given-names></name><name><surname>Lohse</surname><given-names>MJ</given-names></name></person-group>. <article-title>Pathological autoantibodies in cardiomyopathy</article-title>. <source/>Autoimmunity. (<year>2008</year>) <volume>41</volume>:<fpage>454</fpage>–<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1080/08916930802031603</pub-id><pub-id pub-id-type="pmid">18781471</pub-id></mixed-citation>
</ref>
<ref id="B58">
<label>58.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Felker</surname><given-names>GM</given-names></name><name><surname>Thompson</surname><given-names>RE</given-names></name><name><surname>Hare</surname><given-names>JM</given-names></name><name><surname>Hruban</surname><given-names>RH</given-names></name><name><surname>Clemetson</surname><given-names>DE</given-names></name><name><surname>Howard</surname><given-names>DL</given-names></name><etal></etal></person-group>. <article-title>Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy</article-title>. <source/>N Engl J Med. (<year>2000</year>) <volume>342</volume>:<fpage>1077</fpage>–<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1056/NEJM200004133421502</pub-id><pub-id pub-id-type="pmid">10760308</pub-id></mixed-citation>
</ref>
<ref id="B59">
<label>59.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braunwald</surname><given-names>E</given-names></name></person-group>. <article-title>Expanding indications for beta-blockers in heart failure</article-title>. <source/>N Engl J Med. (<year>2001</year>) <volume>344</volume>:<fpage>1711</fpage>–<lpage>2</lpage>. <pub-id pub-id-type="doi">10.1056/NEJM200105313442210</pub-id><pub-id pub-id-type="pmid">11386271</pub-id></mixed-citation>
</ref>
<ref id="B60">
<label>60.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname><given-names>GJ</given-names></name><name><surname>Krahn</surname><given-names>AD</given-names></name><name><surname>Skanes</surname><given-names>AC</given-names></name><name><surname>Yee</surname><given-names>R</given-names></name><name><surname>Gula</surname><given-names>LJ</given-names></name></person-group>. <article-title>Primary prophylaxis of sudden death in hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, and dilated cardiomyopathy</article-title>. <source/>J Cardiovas Electrophys. (<year>2005</year>) <volume>16</volume> (<issue>Suppl. 1</issue>):<fpage>S28</fpage>–<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1111/j.1540-8167.2005.50116.x</pub-id><pub-id pub-id-type="pmid">16138882</pub-id></mixed-citation>
</ref>
<ref id="B61">
<label>61.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Du</surname><given-names>Y</given-names></name><name><surname>Yuan</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>G</given-names></name><name><surname>Tu</surname><given-names>D</given-names></name><etal></etal></person-group>. <article-title>Agonist-like autoantibodies against calcium channel in patients with dilated cardiomyopathy</article-title>. <source/>Heart Vessels. (<year>2012</year>) <volume>27</volume>:<fpage>486</fpage>–<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1007/s00380-011-0176-7</pub-id><pub-id pub-id-type="pmid">21814855</pub-id></mixed-citation>
</ref>
<ref id="B62">
<label>62.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>H</given-names></name><name><surname>Pei</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><etal></etal></person-group>. <article-title>Calcium channel autoantibodies predicted sudden cardiac death and all-cause mortality in patients with ischemic and nonischemic chronic heart failure</article-title>. <source/>Dis Markers. (<year>2014</year>) <volume>2014</volume>:<fpage>796075</fpage>. <pub-id pub-id-type="doi">10.1155/2014/796075</pub-id><pub-id pub-id-type="pmid">24711674</pub-id></mixed-citation>
</ref>
<ref id="B63">
<label>63.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deubner</surname><given-names>N</given-names></name><name><surname>Berliner</surname><given-names>D</given-names></name><name><surname>Schlipp</surname><given-names>A</given-names></name><name><surname>Gelbrich</surname><given-names>G</given-names></name><name><surname>Caforio</surname><given-names>AL</given-names></name><name><surname>Felix</surname><given-names>SB</given-names></name><etal></etal></person-group>. <article-title>Cardiac beta1-adrenoceptor autoantibodies in human heart disease: rationale and design of the Etiology, Titre-Course, and Survival (ETiCS) Study</article-title>. <source/>Eur J Heart Fail. (<year>2010</year>) <volume>12</volume>:<fpage>753</fpage>–<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1093/eurjhf/hfq072</pub-id><pub-id pub-id-type="pmid">20494925</pub-id></mixed-citation>
</ref>
<ref id="B64">
<label>64.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jahns</surname><given-names>R</given-names></name></person-group>
<article-title>Autoantibodies against cardiac troponin I: friend or foe?</article-title>
<source/>Eur J Heart Fail. (<year>2010</year>) <volume>12</volume>:<fpage>645</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1093/eurjhf/hfq098</pub-id><pub-id pub-id-type="pmid">20576833</pub-id></mixed-citation>
</ref>
<ref id="B65">
<label>65.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heymans</surname><given-names>S</given-names></name><name><surname>Hirsch</surname><given-names>E</given-names></name><name><surname>Anker</surname><given-names>SD</given-names></name><name><surname>Aukrust</surname><given-names>P</given-names></name><name><surname>Balligand</surname><given-names>JL</given-names></name><name><surname>Cohen-Tervaert</surname><given-names>JW</given-names></name><etal></etal></person-group>. <article-title>Inflammation as a therapeutic target in heart failure?</article-title> a scientific statement from the translational research committee of the heart failure association of the European Society of Cardiology. <source/>Eur J Heart Fail. (<year>2009</year>) <volume>11</volume>:<fpage>119</fpage>–<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1093/eurjhf/hfn043</pub-id><pub-id pub-id-type="pmid">19168509</pub-id></mixed-citation>
</ref>
<ref id="B66">
<label>66.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sterin-Borda</surname><given-names>L</given-names></name><name><surname>Cossio</surname><given-names>PM</given-names></name><name><surname>Gimeno</surname><given-names>MF</given-names></name><name><surname>Gimeno</surname><given-names>AL</given-names></name><name><surname>Diez</surname><given-names>C</given-names></name><name><surname>Laguens</surname><given-names>RP</given-names></name><etal></etal></person-group>. <article-title>Effect of chagasic sera on the rat isolated atrial preparation: immunological, morphological and function aspects</article-title>. <source/>Cardiovasc Res. (<year>1976</year>) <volume>10</volume>:<fpage>613</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1093/cvr/10.6.613</pub-id><pub-id pub-id-type="pmid">825225</pub-id></mixed-citation>
</ref>
<ref id="B67">
<label>67.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallukat</surname><given-names>G</given-names></name><name><surname>Wollenberger</surname><given-names>A</given-names></name></person-group>. <article-title>Effects of the serum gamma globulin fraction of patients with allergic asthma and dilated cardiomyopathy on chronotropic beta adrenoceptor function in cultured neonatal rat heart myocytes</article-title>. <source/>Biomed Biochim Acta. (<year>1987</year>) <volume>46</volume>:<fpage>S634</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="pmid">2449194</pub-id></mixed-citation>
</ref>
<ref id="B68">
<label>68.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magnusson</surname><given-names>Y</given-names></name><name><surname>Marullo</surname><given-names>S</given-names></name><name><surname>Hoyer</surname><given-names>S</given-names></name><name><surname>Waagstein</surname><given-names>F</given-names></name><name><surname>Andersson</surname><given-names>B</given-names></name><name><surname>Vahlne</surname><given-names>A</given-names></name><etal></etal></person-group>. <article-title>Mapping of a functional autoimmune epitope on the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy</article-title>. <source/>J Clin Invest. (<year>1990</year>) <volume>86</volume>:<fpage>1658</fpage>–<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1172/JCI114888</pub-id><pub-id pub-id-type="pmid">1700798</pub-id></mixed-citation>
</ref>
<ref id="B69">
<label>69.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwata</surname><given-names>M</given-names></name><name><surname>Yoshikawa</surname><given-names>T</given-names></name><name><surname>Baba</surname><given-names>A</given-names></name><name><surname>Anzai</surname><given-names>T</given-names></name><name><surname>Mitamura</surname><given-names>H</given-names></name><name><surname>Ogawa</surname><given-names>S</given-names></name></person-group>. <article-title>Autoantibodies against the second extracellular loop of beta1-adrenergic receptors predict ventricular tachycardia and sudden death in patients with idiopathic dilated cardiomyopathy</article-title>. <source/>J Am Coll Cardiol. (<year>2001</year>) <volume>37</volume>:<fpage>418</fpage>–<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1016/S0735-1097(00)01109-8</pub-id><pub-id pub-id-type="pmid">11216956</pub-id></mixed-citation>
</ref>
<ref id="B70">
<label>70.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magnusson</surname><given-names>Y</given-names></name><name><surname>Wallukat</surname><given-names>G</given-names></name><name><surname>Waagstein</surname><given-names>F</given-names></name><name><surname>Hjalmarson</surname><given-names>A</given-names></name><name><surname>Hoebeke</surname><given-names>J</given-names></name></person-group>. <article-title>Autoimmunity in idiopathic dilated cardiomyopathy. characterization of antibodies against the beta 1-adrenoceptor with positive chronotropic effect</article-title>. <source/>Circulation. (<year>1994</year>) <volume>89</volume>:<fpage>2760</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1161/01.CIR.89.6.2760</pub-id><pub-id pub-id-type="pmid">8205690</pub-id></mixed-citation>
</ref>
<ref id="B71">
<label>71.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magnusson</surname><given-names>Y</given-names></name><name><surname>Hjalmarson</surname><given-names>A</given-names></name><name><surname>Hoebeke</surname><given-names>J</given-names></name></person-group>. <article-title>Beta 1-adrenoceptor autoimmunity in cardiomyopathy</article-title>. <source/>Int J Cardiol. (<year>1996</year>) <volume>54</volume>:<fpage>137</fpage>–<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1016/0167-5273(96)02590-9</pub-id><pub-id pub-id-type="pmid">8803677</pub-id></mixed-citation>
</ref>
<ref id="B72">
<label>72.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christ</surname><given-names>T</given-names></name><name><surname>Wettwer</surname><given-names>E</given-names></name><name><surname>Dobrev</surname><given-names>D</given-names></name><name><surname>Adolph</surname><given-names>E</given-names></name><name><surname>Knaut</surname><given-names>M</given-names></name><name><surname>Wallukat</surname><given-names>G</given-names></name><etal></etal></person-group>. <article-title>Autoantibodies against the beta1 adrenoceptor from patients with dilated cardiomyopathy prolong action potential duration and enhance contractility in isolated cardiomyocytes</article-title>. <source/>J Mol Cell Cardiol. (<year>2001</year>) <volume>33</volume>:<fpage>1515</fpage>–<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1006/jmcc.2001.1414</pub-id><pub-id pub-id-type="pmid">11448139</pub-id></mixed-citation>
</ref>
<ref id="B73">
<label>73.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schulze</surname><given-names>K</given-names></name><name><surname>Heineman</surname><given-names>FW</given-names></name><name><surname>Schultheiss</surname><given-names>HP</given-names></name><name><surname>Balaban</surname><given-names>RS</given-names></name></person-group>. <article-title>Impairment of myocardial calcium homeostasis by antibodies against the adenine nucleotide translocator</article-title>. <source/>Cell Calcium. (<year>1999</year>) <volume>25</volume>:<fpage>361</fpage>–<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1054/ceca.1999.0039</pub-id><pub-id pub-id-type="pmid">10463100</pub-id></mixed-citation>
</ref>
<ref id="B74">
<label>74.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>YH</given-names></name></person-group>. <article-title>Functional analysis of autoantibodies against ADP/ATP carrier from dilated cardiomyopathy</article-title>. <source/>Int J Cardiol. (<year>1996</year>) <volume>54</volume>:<fpage>165</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/0167-5273(96)02594-6</pub-id><pub-id pub-id-type="pmid">8803681</pub-id></mixed-citation>
</ref>
<ref id="B75">
<label>75.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>YH</given-names></name><name><surname>Cheng</surname><given-names>LX</given-names></name><name><surname>Dai</surname><given-names>SP</given-names></name><name><surname>Tu</surname><given-names>YS</given-names></name></person-group>. <article-title>Autoantibodies against ADP/ATP carrier from patients with dilated cardiomyopathy increase activity of voltage-dependent Ca channels in isolated cardiac myocytes</article-title>. <source/>Blood Press Supple. (<year>1996</year>) <volume>3</volume>:<fpage>41</fpage>–<lpage>4</lpage>. <pub-id pub-id-type="pmid">8973768</pub-id></mixed-citation>
</ref>
<ref id="B76">
<label>76.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>YH</given-names></name><name><surname>Yuan</surname><given-names>J</given-names></name></person-group>. <article-title>Progress in the research of targets for the molecular immunotherapy in dilated cardiomyopathy</article-title>. <source/>Zhonghua yi xue za zhi. (<year>2006</year>) <volume>86</volume>:<fpage>1158</fpage>–<lpage>60</lpage>. <pub-id pub-id-type="doi">10.3760/j:issn:0376-2491.2006.17.003</pub-id><pub-id pub-id-type="pmid">16796852</pub-id></mixed-citation>
</ref>
<ref id="B77">
<label>77.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boutjdir</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>ZH</given-names></name><name><surname>Tseng</surname><given-names>CE</given-names></name><name><surname>DiDonato</surname><given-names>F</given-names></name><name><surname>Rashbaum</surname><given-names>W</given-names></name><etal></etal></person-group>. <article-title>Arrhythmogenicity of IgG and anti-52-kD SSA/Ro affinity-purified antibodies from mothers of children with congenital heart block</article-title>. <source/>Circ Res. (<year>1997</year>) <volume>80</volume>:<fpage>354</fpage>–<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.80.3.354</pub-id><pub-id pub-id-type="pmid">9048655</pub-id></mixed-citation>
</ref>
<ref id="B78">
<label>78.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boutjdir</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>ZH</given-names></name><name><surname>Tseng</surname><given-names>CE</given-names></name><name><surname>El-Sherif</surname><given-names>N</given-names></name><name><surname>Buyon</surname><given-names>JP</given-names></name></person-group>. <article-title>Serum and immunoglobulin G from the mother of a child with congenital heart block induce conduction abnormalities and inhibit L-type calcium channels in a rat heart model</article-title>. <source/>Pediatr Res. (<year>1998</year>) <volume>44</volume>:<fpage>11</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1203/00006450-199807000-00002</pub-id><pub-id pub-id-type="pmid">9667364</pub-id></mixed-citation>
</ref>
<ref id="B79">
<label>79.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boutjdir</surname><given-names>M</given-names></name></person-group>. <article-title>Molecular and ionic basis of congenital complete heart block</article-title>. <source/>Trends Cardiovasc Med. (<year>2000</year>) <volume>10</volume>:<fpage>114</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1016/S1050-1738(00)00059-1</pub-id><pub-id pub-id-type="pmid">11427998</pub-id></mixed-citation>
</ref>
<ref id="B80">
<label>80.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lazzerini</surname><given-names>PE</given-names></name><name><surname>Capecchi</surname><given-names>PL</given-names></name><name><surname>Guideri</surname><given-names>F</given-names></name><name><surname>Acampa</surname><given-names>M</given-names></name><name><surname>Selvi</surname><given-names>E</given-names></name><name><surname>Bisogno</surname><given-names>S</given-names></name><etal></etal></person-group>. <article-title>Autoantibody-mediated cardiac arrhythmias: mechanisms and clinical implications</article-title>. <source/>Basic Res Cardiol. (<year>2008</year>) <volume>103</volume>:<fpage>1</fpage>–<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1007/s00395-007-0686-8</pub-id><pub-id pub-id-type="pmid">17999027</pub-id></mixed-citation>
</ref>
<ref id="B81">
<label>81.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miranda-Carus</surname><given-names>ME</given-names></name><name><surname>Boutjdir</surname><given-names>M</given-names></name><name><surname>Tseng</surname><given-names>CE</given-names></name><name><surname>DiDonato</surname><given-names>F</given-names></name><name><surname>Chan</surname><given-names>EK</given-names></name><name><surname>Buyon</surname><given-names>JP</given-names></name></person-group>. <article-title>Induction of antibodies reactive with SSA/Ro-SSB/La and development of congenital heart block in a murine model</article-title>. <source/>J Immunol. (<year>1998</year>) <volume>161</volume>:<fpage>5886</fpage>–<lpage>92</lpage>. <pub-id pub-id-type="pmid">9834068</pub-id></mixed-citation>
</ref>
<ref id="B82">
<label>82.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brucato</surname><given-names>A</given-names></name><name><surname>Franceschini</surname><given-names>F</given-names></name><name><surname>Buyon</surname><given-names>JP</given-names></name></person-group>. <article-title>Neonatal lupus: long-term outcomes of mothers and children and recurrence rate</article-title>. <source/>Clin Exp Rheumatol. (<year>1997</year>) <volume>15</volume>:<fpage>467</fpage>–<lpage>73</lpage>. <pub-id pub-id-type="pmid">9307852</pub-id></mixed-citation>
</ref>
<ref id="B83">
<label>83.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buyon</surname><given-names>JP</given-names></name><name><surname>Winchester</surname><given-names>RJ</given-names></name><name><surname>Slade</surname><given-names>SG</given-names></name><name><surname>Arnett</surname><given-names>F</given-names></name><name><surname>Copel</surname><given-names>J</given-names></name><name><surname>Friedman</surname><given-names>D</given-names></name><etal></etal></person-group>. <article-title>Identification of mothers at risk for congenital heart block and other neonatal lupus syndromes in their children. comparison of enzyme-linked immunosorbent assay and immunoblot for measurement of anti-SS-A/Ro and anti-SS-B/La antibodies</article-title>. <source/>Arthritis Rheum. (<year>1993</year>) <volume>36</volume>:<fpage>1263</fpage>–<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1002/art.1780360911</pub-id><pub-id pub-id-type="pmid">8216420</pub-id></mixed-citation>
</ref>
<ref id="B84">
<label>84.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brucato</surname><given-names>A</given-names></name><name><surname>Frassi</surname><given-names>M</given-names></name><name><surname>Franceschini</surname><given-names>F</given-names></name><name><surname>Cimaz</surname><given-names>R</given-names></name><name><surname>Faden</surname><given-names>D</given-names></name><name><surname>Pisoni</surname><given-names>MP</given-names></name><etal></etal></person-group>. <article-title>Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women</article-title>. <source/>Arthritis Rheum. (<year>2001</year>) <volume>44</volume>:<fpage>1832</fpage>–<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1002/1529-0131(200108)44:8&lt;1832::AID-ART320&gt;3.0.CO;2-C</pub-id><pub-id pub-id-type="pmid">11508435</pub-id></mixed-citation>
</ref>
<ref id="B85">
<label>85.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gordon</surname><given-names>P</given-names></name><name><surname>Khamashta</surname><given-names>MA</given-names></name><name><surname>Rosenthal</surname><given-names>E</given-names></name><name><surname>Simpson</surname><given-names>JM</given-names></name><name><surname>Sharland</surname><given-names>G</given-names></name><name><surname>Brucato</surname><given-names>A</given-names></name><etal></etal></person-group>. <article-title>Anti-52 kDa Ro, anti-60 kDa Ro, and anti-La antibody profiles in neonatal lupus</article-title>. <source/>J Rheumatol. (<year>2004</year>) <volume>31</volume>:<fpage>2480</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="pmid">15570655</pub-id></mixed-citation>
</ref>
<ref id="B86">
<label>86.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franceschini</surname><given-names>F</given-names></name><name><surname>Cavazzana</surname><given-names>I</given-names></name></person-group>. <article-title>Anti-Ro/SSA and La/SSB antibodies</article-title>. <source/>Autoimmunity. (<year>2005</year>) <volume>38</volume>:<fpage>55</fpage>–<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1080/08916930400022954</pub-id><pub-id pub-id-type="pmid">15804706</pub-id></mixed-citation>
</ref>
<ref id="B87">
<label>87.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Satoh</surname><given-names>M</given-names></name><name><surname>Chan</surname><given-names>EK</given-names></name><name><surname>Ho</surname><given-names>LA</given-names></name><name><surname>Rose</surname><given-names>KM</given-names></name><name><surname>Parks</surname><given-names>CG</given-names></name><name><surname>Cohn</surname><given-names>RD</given-names></name><etal></etal></person-group>. <article-title>Prevalence and sociodemographic correlates of antinuclear antibodies in the United States</article-title>. <source/>Arthritis Rheum. (<year>2012</year>) <volume>64</volume>:<fpage>2319</fpage>–<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1002/art.34380</pub-id><pub-id pub-id-type="pmid">22237992</pub-id></mixed-citation>
</ref>
<ref id="B88">
<label>88.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayashi</surname><given-names>N</given-names></name><name><surname>Koshiba</surname><given-names>M</given-names></name><name><surname>Nishimura</surname><given-names>K</given-names></name><name><surname>Sugiyama</surname><given-names>D</given-names></name><name><surname>Nakamura</surname><given-names>T</given-names></name><name><surname>Morinobu</surname><given-names>S</given-names></name><etal></etal></person-group>. <article-title>Prevalence of disease-specific antinuclear antibodies in general population: estimates from annual physical examinations of residents of a small town over a 5-year period</article-title>. <source/>Mod Rheumatol. (<year>2008</year>) <volume>18</volume>:<fpage>153</fpage>–<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1007/s10165-008-0028-1</pub-id><pub-id pub-id-type="pmid">18283522</pub-id></mixed-citation>
</ref>
<ref id="B89">
<label>89.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>YP</given-names></name><name><surname>Wang</surname><given-names>CG</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>YQ</given-names></name><name><surname>Guo</surname><given-names>DL</given-names></name><name><surname>Jing</surname><given-names>XZ</given-names></name><etal></etal></person-group>. <article-title>The prevalence of antinuclear antibodies in the general population of china: a cross-sectional study</article-title>. <source/>Curr Ther Res Clin Exp. (<year>2014</year>) <volume>76</volume>:<fpage>116</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.curtheres.2014.06.004</pub-id><pub-id pub-id-type="pmid">25473438</pub-id></mixed-citation>
</ref>
<ref id="B90">
<label>90.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siren</surname><given-names>MK</given-names></name><name><surname>Julkunen</surname><given-names>H</given-names></name><name><surname>Kaaja</surname><given-names>R</given-names></name></person-group>. <article-title>The increasing incidence of isolated congenital heart block in Finland</article-title>. <source/>J Rheumatol. (<year>1998</year>) <volume>25</volume>:<fpage>1862</fpage>–<lpage>4</lpage>. <pub-id pub-id-type="pmid">9733476</pub-id></mixed-citation>
</ref>
<ref id="B91">
<label>91.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mazel</surname><given-names>JA</given-names></name><name><surname>El-Sherif</surname><given-names>N</given-names></name><name><surname>Buyon</surname><given-names>J</given-names></name><name><surname>Boutjdir</surname><given-names>M</given-names></name></person-group>. <article-title>Electrocardiographic abnormalities in a murine model injected with IgG from mothers of children with congenital heart block</article-title>. <source/>Circulation. (<year>1999</year>) <volume>99</volume>:<fpage>1914</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1161/01.CIR.99.14.1914</pub-id><pub-id pub-id-type="pmid">10199891</pub-id></mixed-citation>
</ref>
<ref id="B92">
<label>92.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>GQ</given-names></name><name><surname>Qu</surname><given-names>Y</given-names></name><name><surname>Hu</surname><given-names>K</given-names></name><name><surname>Boutjdir</surname><given-names>M</given-names></name></person-group>. <article-title>Down-regulation of L-type calcium channel in pups born to 52 kDa SSA/Ro immunized rabbits</article-title>. <source/>FASEB J. (<year>2001</year>) <volume>15</volume>:<fpage>1539</fpage>–<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1096/fj.01-0052com</pub-id><pub-id pub-id-type="pmid">11427485</pub-id></mixed-citation>
</ref>
<ref id="B93">
<label>93.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salomonsson</surname><given-names>S</given-names></name><name><surname>Sonesson</surname><given-names>SE</given-names></name><name><surname>Ottosson</surname><given-names>L</given-names></name><name><surname>Muhallab</surname><given-names>S</given-names></name><name><surname>Olsson</surname><given-names>T</given-names></name><name><surname>Sunnerhagen</surname><given-names>M</given-names></name><etal></etal></person-group>. <article-title>Ro/SSA autoantibodies directly bind cardiomyocytes, disturb calcium homeostasis, and mediate congenital heart block</article-title>. <source/>J Exp Med. (<year>2005</year>) <volume>201</volume>:<fpage>11</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20041859</pub-id><pub-id pub-id-type="pmid">15630133</pub-id></mixed-citation>
</ref>
<ref id="B94">
<label>94.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>H</given-names></name><name><surname>Silverman</surname><given-names>ED</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Borges</surname><given-names>C</given-names></name><name><surname>Zhao</surname><given-names>S</given-names></name><name><surname>Isacovics</surname><given-names>B</given-names></name><etal></etal></person-group>. <article-title>Effect of maternal autoantibodies on fetal cardiac conduction: an experimental murine model</article-title>. <source/>Pediatr Res. (<year>2005</year>) <volume>57</volume>:<fpage>557</fpage>–<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1203/01.PDR.0000155947.82365.E4</pub-id><pub-id pub-id-type="pmid">15695601</pub-id></mixed-citation>
</ref>
<ref id="B95">
<label>95.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Menon</surname><given-names>A</given-names></name><name><surname>Silverman</surname><given-names>ED</given-names></name><name><surname>Gow</surname><given-names>RM</given-names></name><name><surname>Hamilton</surname><given-names>RM</given-names></name></person-group>. <article-title>Chronotropic competence of the sinus node in congenital complete heart block</article-title>. <source/>Am J Cardiol. (<year>1998</year>) <volume>82</volume>:<fpage>1119</fpage>–<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1016/S0002-9149(98)00569-4</pub-id><pub-id pub-id-type="pmid">9817493</pub-id></mixed-citation>
</ref>
<ref id="B96">
<label>96.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brucato</surname><given-names>A</given-names></name><name><surname>Cimaz</surname><given-names>R</given-names></name><name><surname>Catelli</surname><given-names>L</given-names></name><name><surname>Meroni</surname><given-names>P</given-names></name></person-group>. <article-title>Anti-Ro-associated sinus bradycardia in newborns</article-title>. <source/>Circulation. (<year>2000</year>) <volume>102</volume>:<fpage>E88</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1161/01.CIR.102.11.e88</pub-id><pub-id pub-id-type="pmid">10982556</pub-id></mixed-citation>
</ref>
<ref id="B97">
<label>97.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendez</surname><given-names>C</given-names></name><name><surname>Zipes</surname><given-names>DP</given-names></name></person-group>. <article-title>Possible ionic mechanism of the action potentials of the atrioventricular node of rabbits</article-title>. <source/>Bol Estud Med Biol. (<year>1974</year>) (<issue>Suppl 1</issue>):<fpage>67</fpage>–<lpage>80</lpage>. <pub-id pub-id-type="pmid">4464886</pub-id></mixed-citation>
</ref>
<ref id="B98">
<label>98.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>K</given-names></name><name><surname>Qu</surname><given-names>Y</given-names></name><name><surname>Yue</surname><given-names>Y</given-names></name><name><surname>Boutjdir</surname><given-names>M</given-names></name></person-group>. <article-title>Functional basis of sinus bradycardia in congenital heart block</article-title>. <source/>Circ Res. (<year>2004</year>) <volume>94</volume>:<fpage>e32</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.0000121566.01778.06</pub-id><pub-id pub-id-type="pmid">14963005</pub-id></mixed-citation>
</ref>
<ref id="B99">
<label>99.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qu</surname><given-names>Y</given-names></name><name><surname>Xiao</surname><given-names>GQ</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Boutjdir</surname><given-names>M</given-names></name></person-group>. <article-title>Autoantibodies from mothers of children with congenital heart block downregulate cardiac L-type Ca channels</article-title>. <source/>J Mol Cell Cardiol. (<year>2001</year>) <volume>33</volume>:<fpage>1153</fpage>–<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1006/jmcc.2001.1379</pub-id><pub-id pub-id-type="pmid">11444920</pub-id></mixed-citation>
</ref>
<ref id="B100">
<label>100.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>GQ</given-names></name><name><surname>Hu</surname><given-names>K</given-names></name><name><surname>Boutjdir</surname><given-names>M</given-names></name></person-group>. <article-title>Direct inhibition of expressed cardiac l- and t-type calcium channels by IGG from mothers whose children have congenital heart block</article-title>. <source/>Circulation. (<year>2001</year>) <volume>103</volume>:<fpage>1599</fpage>–<lpage>604</lpage>. <pub-id pub-id-type="doi">10.1161/01.CIR.103.11.1599</pub-id><pub-id pub-id-type="pmid">11257091</pub-id></mixed-citation>
</ref>
<ref id="B101">
<label>101.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takimoto</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>D</given-names></name><name><surname>Nerbonne</surname><given-names>JM</given-names></name><name><surname>Levitan</surname><given-names>ES</given-names></name></person-group>. <article-title>Distribution, splicing and glucocorticoid-induced expression of cardiac alpha 1C and alpha 1D voltage-gated Ca2+ channel mRNAs</article-title>. <source/>J Mol Cell Cardiol. (<year>1997</year>) <volume>29</volume>:<fpage>3035</fpage>–<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1006/jmcc.1997.0532</pub-id><pub-id pub-id-type="pmid">9405178</pub-id></mixed-citation>
</ref>
<ref id="B102">
<label>102.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matthes</surname><given-names>J</given-names></name><name><surname>Yildirim</surname><given-names>L</given-names></name><name><surname>Wietzorrek</surname><given-names>G</given-names></name><name><surname>Reimer</surname><given-names>D</given-names></name><name><surname>Striessnig</surname><given-names>J</given-names></name><name><surname>Herzig</surname><given-names>S</given-names></name></person-group>. <article-title>Disturbed atrio-ventricular conduction and normal contractile function in isolated hearts from Cav1.3-knockout mice</article-title>. <source/>Naunyn Schmiedebergs Arch Pharmacol. (<year>2004</year>) <volume>369</volume>:<fpage>554</fpage>–<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1007/s00210-004-0940-7</pub-id><pub-id pub-id-type="pmid">15146309</pub-id></mixed-citation>
</ref>
<ref id="B103">
<label>103.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karnabi</surname><given-names>E</given-names></name><name><surname>Qu</surname><given-names>Y</given-names></name><name><surname>Mancarella</surname><given-names>S</given-names></name><name><surname>Yue</surname><given-names>Y</given-names></name><name><surname>Wadgaonkar</surname><given-names>R</given-names></name><name><surname>Boutjdir</surname><given-names>M</given-names></name></person-group>. <article-title>Silencing of Cav1.2 gene in neonatal cardiomyocytes by lentiviral delivered shRNA</article-title>. <source/>Biochem Biophys Res Commun. (<year>2009</year>) <volume>384</volume>:<fpage>409</fpage>–<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2009.04.150</pub-id><pub-id pub-id-type="pmid">19422800</pub-id></mixed-citation>
</ref>
<ref id="B104">
<label>104.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamilton</surname><given-names>RM</given-names></name><name><surname>Lee-Poy</surname><given-names>M</given-names></name><name><surname>Kruger</surname><given-names>K</given-names></name><name><surname>Silverman</surname><given-names>ED</given-names></name></person-group>. <article-title>Investigative methods of congenital complete heart block</article-title>. <source/>J Electrocardiol. (<year>1998</year>) <volume>30</volume>:<fpage>69</fpage>–<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1016/S0022-0736(98)80035-6</pub-id><pub-id pub-id-type="pmid">9535483</pub-id></mixed-citation>
</ref>
<ref id="B105">
<label>105.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia</surname><given-names>S</given-names></name><name><surname>Nascimento</surname><given-names>JH</given-names></name><name><surname>Bonfa</surname><given-names>E</given-names></name><name><surname>Levy</surname><given-names>R</given-names></name><name><surname>Oliveira</surname><given-names>SF</given-names></name><name><surname>Tavares</surname><given-names>AV</given-names></name><etal></etal></person-group>. <article-title>Cellular mechanism of the conduction abnormalities induced by serum from anti-Ro/SSA-positive patients in rabbit hearts</article-title>. <source/>J Clin Invest. (<year>1994</year>) <volume>93</volume>:<fpage>718</fpage>–<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1172/JCI117025</pub-id><pub-id pub-id-type="pmid">8113406</pub-id></mixed-citation>
</ref>
<ref id="B106">
<label>106.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Restivo</surname><given-names>M</given-names></name><name><surname>Kozhevnikov</surname><given-names>DO</given-names></name><name><surname>Boutjdir</surname><given-names>M</given-names></name></person-group>. <article-title>Optical mapping of activation patterns in an animal model of congenital heart block</article-title>. <source/>Am J Physiol Heart Circ Physiol. (<year>2001</year>) <volume>280</volume>:<fpage>H1889</fpage>–<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.2001.280.4.H1889</pub-id><pub-id pub-id-type="pmid">11247806</pub-id></mixed-citation>
</ref>
<ref id="B107">
<label>107.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strandberg</surname><given-names>LS</given-names></name><name><surname>Cui</surname><given-names>X</given-names></name><name><surname>Rath</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Silverman</surname><given-names>ED</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><etal></etal></person-group>. <article-title>Congenital heart block maternal sera autoantibodies target an extracellular epitope on the alpha1G T-type calcium channel in human fetal hearts</article-title>. <source/>PLoS ONE. (<year>2013</year>) <volume>8</volume>:<fpage>e72668</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0072668</pub-id><pub-id pub-id-type="pmid">24039792</pub-id></mixed-citation>
</ref>
<ref id="B108">
<label>108.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karnabi</surname><given-names>E</given-names></name><name><surname>Qu</surname><given-names>Y</given-names></name><name><surname>Wadgaonkar</surname><given-names>R</given-names></name><name><surname>Mancarella</surname><given-names>S</given-names></name><name><surname>Yue</surname><given-names>Y</given-names></name><name><surname>Chahine</surname><given-names>M</given-names></name><etal></etal></person-group>. <article-title>Congenital heart block: identification of autoantibody binding site on the extracellular loop (domain I, S5-S6) of alpha(1D) L-type Ca channel</article-title>. <source/>J Autoimmun. (<year>2010</year>) <volume>34</volume>:<fpage>80</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaut.2009.06.005</pub-id><pub-id pub-id-type="pmid">19640679</pub-id></mixed-citation>
</ref>
<ref id="B109">
<label>109.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>CC</given-names></name><name><surname>Lamping</surname><given-names>KG</given-names></name><name><surname>Nuno</surname><given-names>DW</given-names></name><name><surname>Barresi</surname><given-names>R</given-names></name><name><surname>Prouty</surname><given-names>SJ</given-names></name><name><surname>Lavoie</surname><given-names>JL</given-names></name><etal></etal></person-group>. <article-title>Abnormal coronary function in mice deficient in alpha1H T-type Ca2+ channels</article-title>. <source/>Science. (<year>2003</year>) <volume>302</volume>:<fpage>1416</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1126/science.1089268</pub-id><pub-id pub-id-type="pmid">14631046</pub-id></mixed-citation>
</ref>
<ref id="B110">
<label>110.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Markham</surname><given-names>AJ</given-names></name><name><surname>Rasmussen</surname><given-names>SE</given-names></name><name><surname>Salmon</surname><given-names>JE</given-names></name><name><surname>Martinez-Ortiz</surname><given-names>W</given-names></name><name><surname>Cardozo</surname><given-names>TJ</given-names></name><name><surname>Clancy</surname><given-names>RM</given-names></name><etal></etal></person-group>. <article-title>Reactivity to the p305 epitope of the alpha1G T-type calcium channel and autoimmune-associated congenital heart block</article-title>. <source/>J Am Heart Assoc. (<year>2015</year>) <volume>4</volume>:<fpage>e001836</fpage>. <pub-id pub-id-type="doi">10.1161/JAHA.115.001836</pub-id><pub-id pub-id-type="pmid">25994441</pub-id></mixed-citation>
</ref>
<ref id="B111">
<label>111.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cimaz</surname><given-names>R</given-names></name><name><surname>Stramba-Badiale</surname><given-names>M</given-names></name><name><surname>Brucato</surname><given-names>A</given-names></name><name><surname>Catelli</surname><given-names>L</given-names></name><name><surname>Panzeri</surname><given-names>P</given-names></name><name><surname>Meroni</surname><given-names>PL</given-names></name></person-group>. <article-title>QT interval prolongation in asymptomatic anti-SSA/Ro-positive infants without congenital heart block</article-title>. <source/>Arthritis Rheum. (<year>2000</year>) <volume>43</volume>:<fpage>1049</fpage>–<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1002/1529-0131(200005)43:5&lt;1049::AID-ANR13&gt;3.0.CO;2-X</pub-id><pub-id pub-id-type="pmid">10817558</pub-id></mixed-citation>
</ref>
<ref id="B112">
<label>112.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cimaz</surname><given-names>R</given-names></name><name><surname>Meroni</surname><given-names>PL</given-names></name><name><surname>Brucato</surname><given-names>A</given-names></name><name><surname>Fesstova</surname><given-names>V</given-names></name><name><surname>Panzeri</surname><given-names>P</given-names></name><name><surname>Goulene</surname><given-names>K</given-names></name><etal></etal></person-group>. <article-title>Concomitant disappearance of electrocardiographic abnormalities and of acquired maternal autoantibodies during the first year of life in infants who had QT interval prolongation and anti-SSA/Ro positivity without congenital heart block at birth</article-title>. <source/>Arthritis Rheum. (<year>2003</year>) <volume>48</volume>:<fpage>266</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1002/art.10700</pub-id><pub-id pub-id-type="pmid">12528128</pub-id></mixed-citation>
</ref>
<ref id="B113">
<label>113.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bourre-Tessier</surname><given-names>J</given-names></name><name><surname>Clarke</surname><given-names>AE</given-names></name><name><surname>Huynh</surname><given-names>T</given-names></name><name><surname>Bernatsky</surname><given-names>S</given-names></name><name><surname>Joseph</surname><given-names>L</given-names></name><name><surname>Belisle</surname><given-names>P</given-names></name><etal></etal></person-group>. <article-title>Prolonged corrected QT interval in anti-Ro/SSA-positive adults with systemic lupus erythematosus</article-title>. <source/>Arthritis Care Res. (<year>2011</year>) <volume>63</volume>:<fpage>1031</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1002/acr.20470</pub-id><pub-id pub-id-type="pmid">21452253</pub-id></mixed-citation>
</ref>
<ref id="B114">
<label>114.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lazzerini</surname><given-names>PE</given-names></name><name><surname>Capecchi</surname><given-names>PL</given-names></name><name><surname>Acampa</surname><given-names>M</given-names></name><name><surname>Morozzi</surname><given-names>G</given-names></name><name><surname>Bellisai</surname><given-names>F</given-names></name><name><surname>Bacarelli</surname><given-names>MR</given-names></name><etal></etal></person-group>. <article-title>Anti-Ro/SSA-associated corrected QT interval prolongation in adults: the role of antibody level and specificity</article-title>. <source/>Arthritis Care Res. (<year>2011</year>) <volume>63</volume>:<fpage>1463</fpage>–<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1002/acr.20540</pub-id><pub-id pub-id-type="pmid">21739618</pub-id></mixed-citation>
</ref>
<ref id="B115">
<label>115.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tufan</surname><given-names>AN</given-names></name><name><surname>Sag</surname><given-names>S</given-names></name><name><surname>Oksuz</surname><given-names>MF</given-names></name><name><surname>Ermurat</surname><given-names>S</given-names></name><name><surname>Coskun</surname><given-names>BN</given-names></name><name><surname>Gullulu</surname><given-names>M</given-names></name><etal></etal></person-group>. <article-title>Prolonged Tpeak-Tend interval in anti-Ro52 antibody-positive connective tissue diseases</article-title>. <source/>Rheumatol Int. (<year>2017</year>) <volume>37</volume>:<fpage>67</fpage>–<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1007/s00296-016-3488-1</pub-id><pub-id pub-id-type="pmid">27193468</pub-id></mixed-citation>
</ref>
<ref id="B116">
<label>116.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lazzerini</surname><given-names>PE</given-names></name><name><surname>Capecchi</surname><given-names>PL</given-names></name><name><surname>Guideri</surname><given-names>F</given-names></name><name><surname>Bellisai</surname><given-names>F</given-names></name><name><surname>Selvi</surname><given-names>E</given-names></name><name><surname>Acampa</surname><given-names>M</given-names></name><etal></etal></person-group>. <article-title>Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease</article-title>. <source/>Am J Cardiol. (<year>2007</year>) <volume>100</volume>:<fpage>1029</fpage>–<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1016/j.amjcard.2007.04.048</pub-id><pub-id pub-id-type="pmid">17826392</pub-id></mixed-citation>
</ref>
<ref id="B117">
<label>117.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duke</surname><given-names>C</given-names></name><name><surname>Stuart</surname><given-names>G</given-names></name><name><surname>Simpson</surname><given-names>JM</given-names></name></person-group>. <article-title>Ventricular tachycardia secondary to prolongation of the QT interval in a fetus with autoimmune mediated congenital complete heart block</article-title>. <source/>Cardiol Young. (<year>2005</year>) <volume>15</volume>:<fpage>319</fpage>–<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1017/S1047951105000673</pub-id><pub-id pub-id-type="pmid">15865840</pub-id></mixed-citation>
</ref>
<ref id="B118">
<label>118.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>K</given-names></name><name><surname>Katayama</surname><given-names>Y</given-names></name><name><surname>Kusano</surname><given-names>KF</given-names></name><name><surname>Haraoka</surname><given-names>K</given-names></name><name><surname>Tani</surname><given-names>Y</given-names></name><name><surname>Nagase</surname><given-names>S</given-names></name><etal></etal></person-group>. <article-title>Anti-KCNH2 antibody-induced long QT syndrome: novel acquired form of long QT syndrome</article-title>. <source/>J Am Coll Cardiol. (<year>2007</year>) <volume>50</volume>:<fpage>1808</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacc.2007.07.037</pub-id><pub-id pub-id-type="pmid">17964047</pub-id></mixed-citation>
</ref>
<ref id="B119">
<label>119.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lazzerini</surname><given-names>PE</given-names></name><name><surname>Yue</surname><given-names>Y</given-names></name><name><surname>Srivastava</surname><given-names>U</given-names></name><name><surname>Fabris</surname><given-names>F</given-names></name><name><surname>Capecchi</surname><given-names>PL</given-names></name><name><surname>Bertolozzi</surname><given-names>I</given-names></name><etal></etal></person-group>. <article-title>Arrhythmogenicity of anti-Ro/SSA antibodies in patients with torsades de pointes</article-title>. <source/>Circ Arrhythm Electrophysiol. (<year>2016</year>) <volume>9</volume>:<fpage>e003419</fpage>. <pub-id pub-id-type="doi">10.1161/CIRCEP.115.003419</pub-id><pub-id pub-id-type="pmid">27030700</pub-id></mixed-citation>
</ref>
<ref id="B120">
<label>120.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mancarella</surname><given-names>S</given-names></name><name><surname>Yue</surname><given-names>Y</given-names></name><name><surname>Karnabi</surname><given-names>E</given-names></name><name><surname>Qu</surname><given-names>Y</given-names></name><name><surname>El-Sherif</surname><given-names>N</given-names></name><name><surname>Boutjdir</surname><given-names>M</given-names></name></person-group>. <article-title>Impaired Ca2+ homeostasis is associated with atrial fibrillation in the alpha1D L-type Ca2+ channel KO mouse</article-title>. <source/>Am J Physiol Heart Circ Physiol. (<year>2008</year>) <volume>295</volume>:<fpage>H2017</fpage>–<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.00537.2008</pub-id><pub-id pub-id-type="pmid">18790836</pub-id></mixed-citation>
</ref>
<ref id="B121">
<label>121.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Izmirly</surname><given-names>P</given-names></name><name><surname>Saxena</surname><given-names>A</given-names></name><name><surname>Buyon</surname><given-names>JP</given-names></name></person-group>. <article-title>Progress in the pathogenesis and treatment of cardiac manifestations of neonatal lupus</article-title>. <source/>Curr Opin Rheumatol. (<year>2017</year>) <volume>29</volume>:<fpage>467</fpage>–<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1097/BOR.0000000000000414</pub-id><pub-id pub-id-type="pmid">28520682</pub-id></mixed-citation>
</ref>
<ref id="B122">
<label>122.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clancy</surname><given-names>RM</given-names></name><name><surname>Neufing</surname><given-names>PJ</given-names></name><name><surname>Zheng</surname><given-names>P</given-names></name><name><surname>O'Mahony</surname><given-names>M</given-names></name><name><surname>Nimmerjahn</surname><given-names>F</given-names></name><name><surname>Gordon</surname><given-names>TP</given-names></name><etal></etal></person-group>. <article-title>Impaired clearance of apoptotic cardiocytes is linked to anti-SSA/Ro and -SSB/La antibodies in the pathogenesis of congenital heart block</article-title>. <source/>J Clin Invest. (<year>2006</year>) <volume>116</volume>:<fpage>2413</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1172/JCI27803</pub-id><pub-id pub-id-type="pmid">16906225</pub-id></mixed-citation>
</ref>
<ref id="B123">
<label>123.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brito-Zerón</surname><given-names>P</given-names></name><name><surname>Izmirly</surname><given-names>PM</given-names></name><name><surname>Ramos-Casals</surname><given-names>M</given-names></name><name><surname>Buyon</surname><given-names>JP</given-names></name><name><surname>Khamashta</surname><given-names>MA</given-names></name></person-group>. <article-title>The clinical spectrum of autoimmune congenital heart block</article-title>. <source/>Nat Rev Rheumatol. (<year>2015</year>) <volume>11</volume>:<fpage>301</fpage>–<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1038/nrrheum.2015.29</pub-id><pub-id pub-id-type="pmid">25800217</pub-id></mixed-citation>
</ref>
<ref id="B124">
<label>124.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Litsey</surname><given-names>SE</given-names></name><name><surname>Noonan</surname><given-names>JA</given-names></name><name><surname>O'Connor</surname><given-names>WN</given-names></name><name><surname>Cottrill</surname><given-names>CM</given-names></name><name><surname>Mitchell</surname><given-names>B</given-names></name></person-group>. <article-title>Maternal connective tissue disease and congenital heart block. demonstration of immunoglobulin in cardiac tissue</article-title>. <source/>N Engl J Med. (<year>1985</year>) <volume>312</volume>:<fpage>98</fpage>–<lpage>100</lpage>. <pub-id pub-id-type="doi">10.1056/NEJM198501103120206</pub-id><pub-id pub-id-type="pmid">3880599</pub-id></mixed-citation>
</ref>
<ref id="B125">
<label>125.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname><given-names>SY</given-names></name><name><surname>Esscher</surname><given-names>E</given-names></name><name><surname>Anderson</surname><given-names>RH</given-names></name><name><surname>Michaelsson</surname><given-names>M</given-names></name></person-group>. <article-title>Anatomy of congenital complete heart block and relation to maternal anti-Ro antibodies</article-title>. <source/>Am J Cardiol. (<year>1986</year>) <volume>58</volume>:<fpage>291</fpage>–<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1016/0002-9149(86)90064-0</pub-id><pub-id pub-id-type="pmid">3090867</pub-id></mixed-citation>
</ref>
<ref id="B126">
<label>126.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tonello</surname><given-names>M</given-names></name><name><surname>Ruffatti</surname><given-names>A</given-names></name><name><surname>Favaro</surname><given-names>M</given-names></name><name><surname>Tison</surname><given-names>T</given-names></name><name><surname>Del Ross</surname><given-names>T</given-names></name><name><surname>Calligaro</surname><given-names>A</given-names></name><etal></etal></person-group>. <article-title>Maternal autoantibody profiles at risk for autoimmune congenital heart block: a prospective study in high-risk patients</article-title>. <source/>Lupus Sci Med. (<year>2016</year>) <volume>3</volume>:<fpage>e000129</fpage>. <pub-id pub-id-type="doi">10.1136/lupus-2015-000129</pub-id><pub-id pub-id-type="pmid">27026811</pub-id></mixed-citation>
</ref>
<ref id="B127">
<label>127.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reed</surname><given-names>JH</given-names></name><name><surname>Clancy</surname><given-names>RM</given-names></name><name><surname>Lee</surname><given-names>KH</given-names></name><name><surname>Saxena</surname><given-names>A</given-names></name><name><surname>Izmirly</surname><given-names>PM</given-names></name><name><surname>Buyon</surname><given-names>JP</given-names></name></person-group>. <article-title>Umbilical cord blood levels of maternal antibodies reactive with p200 and full-length Ro 52 in the assessment of risk for cardiac manifestations of neonatal lupus</article-title>. <source/>Arthritis Care Res. (<year>2012</year>) <volume>64</volume>:<fpage>1373</fpage>–<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1002/acr.21704</pub-id><pub-id pub-id-type="pmid">22511615</pub-id></mixed-citation>
</ref>
<ref id="B128">
<label>128.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Izmirly</surname><given-names>PM</given-names></name><name><surname>Saxena</surname><given-names>A</given-names></name></person-group>. <article-title>In search of an antibody specificity highly predictive of congenital heart block</article-title>. <source/>Lupus Sci Med. (<year>2016</year>) <volume>3</volume>:<fpage>e000154</fpage>. <pub-id pub-id-type="doi">10.1136/lupus-2016-000154</pub-id><pub-id pub-id-type="pmid">27158527</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>